Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 45(1); 2013 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
Kyu-Won Jung, MS1, Young-Joo Won, PhD1, Hyun-Joo Kong, MS1, Chang-Mo Oh, MD1, Hong Gwan Seo, MD, PhD2, Jin-Soo Lee, MD, PhD1
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2013;45(1):1-14.
DOI: https://doi.org/10.4143/crt.2013.45.1.1
Published online: March 31, 2013

1The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, Korea.

2National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Correspondence: Young-Joo Won, PhD. The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2015, Fax: 82-31-920-2179, astra67@ncc.re.kr
• Received: February 26, 2013   • Accepted: February 27, 2013

Copyright © 2013 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 39,206 Views
  • 291 Download
  • 376 Crossref
  • 357 Scopus
next
  • Purpose
    This article gives an overview of nationwide cancer statistics, including incidence, mortality, survival and prevalence, and their trends in Korea based on 2010 cancer incidence data.
  • Materials and Methods
    Incidence data from 1993 to 2010 were obtained from the Korea National Cancer Incidence Database, and vital status was followed until 31 December 2011. Mortality data from 1983 to 2010 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, prevalence, and relative survival were calculated.
  • Results
    In total, 202,053 cancer cases and 72,046 cancer deaths occurred during 2010, and 960,654 prevalent cancer cases were identified in Korea as of 1 January 2011. The incidence of all cancers combined showed an annual increase of 3.3% from 1999 to 2010. The incidences of liver and cervical cancers have decreased while those of thyroid, breast, prostate and colorectal cancers have increased. Notably, thyroid cancer, which is the most common cancer in Korea, increased by 24.2% per year rapidly in both sexes. The mortality of all cancers combined showed a decrease by 2.7% annually from 2002 to 2010. Five-year relative survival rates of patients who were diagnosed with cancer from 2006 to 2011 had improved by 22.9% compared with those from 1993 to 1995.
  • Conclusion
    While the overall cancer incidence in Korea has increased rapidly, age-standardized cancer mortality rates have declined since 2002 and survival has improved.
Cancer has been the leading cause of death in Korea since 1983 [1] and is associated with the largest disease burden [2]. More than 190,000 new cancer cases are diagnosed annually in Korea, and one in four deaths results from cancer [3,4]. This article provides an overview of nationwide cancer statistics, including the incidence, mortality, prevalence and survival rates, and their trends.
1. Data sources
The Ministry of Health and Welfare, Korea, initiated a nationwide hospital-based cancer registry called the Korea Central Cancer Registry (KCCR) as early as 1980. The registry collected 80-90% of cancer cases annually from more than 180 training hospitals throughout the country. In 1999, the KCCR expanded cancer registration to cover the entire population under the Population-Based Regional Cancer Registry program. Details of the history, objectives and activities of the KCCR have been documented [5]. Incidence data from 1999 to 2010 were obtained from the Korea National Cancer Incidence Database (KNCI DB). The completeness of incidence data for 2010 was 97.1%, as determined by the Ajiki method [6].
Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [7] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [8]. The survival analysis used 1,992,568 cancer cases first diagnosed during 1993-2010 from the KNCI DB, and followed vital status until 31 December 2011.
Mortality data from 1983-2010 were obtained from Statistics Korea [1]. Cause of death was coded and classified according to ICD-10. Population data were also obtained from Statistics Korea using the resident registration population on July 1 of specified years.
2. Analysis
Crude rates (CRs) and age-specific rates of cancer incidence and mortality were calculated. Age-standardized rates (ASRs) were determined using the world standard population [9]. Cumulative risks of cancer, which represent the probability of developing cancer during one's lifetime, were also calculated. Changes in the annual ASRs of cancer incidence were examined by calculating the annual percentage change over a time period as (exp(b)-1)×100, where b is the slope of the regression of log ASR for a given calendar year [10].
Prevalence was also calculated to assess the cancer burden, which reflects new and pre-existing cancer patients diagnosed during a given period of time still alive on an index date. Using cancer incidence database data from 1999 to 2010, we defined prevalent cases on January 1, 2011 as patients who were diagnosed between January 1, 1999 and December 31, 2010 and who were alive on January 1, 2011. We calculated limited-duration prevalences, such as the 1- and 5-year prevalences. For example, the 5-year prevalence was calculated as the number of people alive on January 1, 2011 who had been diagnosed with cancer within the previous 5 years. We applied this counting method using the SEER*Stat software [11] to calculate the number of cases, while adjusting for patients lost to follow-up [10].
The survival duration for each case was determined as the interval between the date of initial diagnosis and the date of death, date of loss to follow-up, or closing date for follow-up. Observed survival rates were calculated using the life-table method and relative survival rates by the Ederer II method [12] using an algorithm written in SAS by Dickman [13], with some minor modifications.
1. Incidence
Table 1 presents the overall number of incident cancer cases, deaths, and prevalent cases during 2010 in Korea by sex and cancer site. In 2010, 202,053 incident cancer cases and 72,046 deaths were identified. As of 1 January 2011, 960,654 prevalent cancer cases diagnosed between 1999 and 2010 were identified. In 2010, the cumulative risk of developing cancer during one's lifetime was 37.6% for males and 33.3% for females.
Table 2 shows cancer incidence rates in 2010 by sex. The CRs of all sites combined in 2010 were 412.4 and 397.7 per 100,000 in males and females, respectively. The ASRs of all sites combined were 324.1 and 268.7 per 100,000 in males and females, respectively. In males, the five leading primary cancer sites were the stomach (CR, 80.8; ASR, 62.3), colon and rectum (CR, 62.5; ASR, 48.6), lung (CR, 58.7; ASR, 46.5), liver (CR, 47.3; ASR, 36.0), and prostate (CR, 31.4; ASR, 25.3), which together accounted for 68.1% of all newly diagnosed cancers in 2010. In females, the most common cancer sites were the thyroid (CR, 119.6; ASR, 87.4), breast (CR, 57.1; ASR, 39.8), colon and rectum (CR, 40.8; ASR, 25.3), stomach (CR, 39.8; ASR, 24.9), lung (CR, 24.3; ASR, 14.3), and liver (CR, 16.5; ASR, 10.2), which together accounted for 70.8% of all newly diagnosed cancers. Thyroid cancer alone accounted for 30.1% of incident cases (n=29,790) in females in 2010.
2. Mortality
In total, 72,046 cancer deaths were reported in Korea during 2010, accounting for 28.2% of all deaths (Table 3). In 2010, the CRs for all sites combined were 181.0 and 107.8 per 100,000 in males and females, respectively. The ASRs of all sites combined were 144.7 and 61.6 per 100,000 for males and females, respectively. Cancers of the lung, liver, stomach, and colon/rectum were the most common fatal cancers, together accounting for about 61.8% of all cancer deaths in 2010 (Table 4).
In males, the five leading fatal primary cancer sites in 2010 were the lung (CR, 45.7; ASR, 36.6), liver (CR, 33.4; ASR, 25.8), stomach (CR, 26.1; ASR, 20.7), colon and rectum (CR, 17.3; ASR, 14.0) and pancreas (CR, 9.3; ASR, 7.4). In women, lung cancer (CR, 16.9; ASR, 9.1) was the most fatal cancer site in 2010, followed by the stomach (CR, 14.1; ASR, 7.8), colon and rectum (CR, 13.3; ASR, 7.3), liver (CR, 11.5; ASR, 6.6), and breast (CR, 7.5; ASR, 5.0).
3. Trends in cancer incidence
Tables 5-7 present the cancer incidence rates during 1999-2010 in Korea for all sites combined and for selected sites. The incidence for all sites combined increased by 3.3% annually (1.5% in males, 5.3% in females) from 1999 to 2010.
The rapid increase in cancer incidence is also illustrated in Fig. 1. As shown in Fig. 2, the incidence rates of colorectal and thyroid cancers have continued to increase in both sexes, as have those of prostate cancer in males and breast cancer in females. In contrast, the incidences of liver cancer in both sexes, lung cancer in males and cervical cancer in females have decreased. Stomach cancer incidence rates remained the same in males and females. One notable trend was the sharp (24.2% annual) increase in the incidence of thyroid cancer in both sexes. Improvements in the sensitivity of diagnostic techniques for thyroid cancer, such as the advent of ultrasound and fine-needle aspiration, have enabled the detection of subclinical disease. Therefore, the increased incidence of thyroid cancer may reflect the identification of previously undetected disease with these improved diagnostic techniques and increased screening rates, rather than a true increase in the occurrence of thyroid cancer [14-17]. Furthermore, due to the construction of a 1999-2010 KNCI DB, the completeness of the Korea cancer registry data has improved gradually, and this may have contributed, in part, to the gradual overall increases in cancer incidence, particularly among elderly patients.
4. Age-specific incidence rates
Table 8 presents the most common cancer sites by sex and age group in 2010. Leukemia and thyroid cancer were the most common cancer in both sexes in subjects aged 0-14 and 15-34 years, respectively. For males, stomach cancer was the most common cancer in 35-64-year-olds, while lung cancer was more frequent among patients aged ≥65 years. Thyroid cancer was the most common cancer in middle-aged Korean females (age, 35 to 64 years), and colorectal cancer was the most common cancer among older females (≥65 years).
Fig. 3 shows the age-specific incidence rates for selected cancers in males and females in 2010. The data show that the incidences of stomach, lung, liver, and colorectal cancers increased gradually with age. Incidences of breast and thyroid cancers in females were highest in those in their late 40s and early 50s, respectively, and leveled off thereafter. This pattern is different from those in Western countries [18].
5. Trends in cancer mortality
Figs. 1 and 4 show the trends in cancer deaths for all sites combined and for selected sites. ASRs of mortality showed an annual decrease of 2.7% for all sites combined in both sexes since 2002. Lung cancer surpassed stomach cancer as the leading cause of cancer deaths in 1999 and is expected to account for 21.7% of all cancer deaths in 2010. The ASRs of mortality due to lung cancer have decreased slightly in males since 2001, but have increased in females. The ASRs of mortality due to stomach and cervical cancers have decreased continuously. Along with the significant increases in colorectal, prostate and female breast cancer incidence rates, the mortality rates of these cancers have also continued to increase.
6. Survival rates
Table 9 shows the 5-year relative survival rates for four diagnosis periods: 1993-1995, 1996-2000, 2001-2005, and 2006-2010. Patients who were diagnosed with cancer in the most recent period (2006-2010) had a 5-year relative survival rate of 64.1% for all sites combined in both sexes (55.4% in males and 73.3% in females). When compared with earlier periods, notable improvements in the 5-year relative survival rates were observed for all sites combined. The higher cancer survival rate in females than in males may be partly explained by cancers common in females (e.g., thyroid, breast, and cervix cancers) having relatively good prognoses.
When examined by year of diagnosis and cancer site, the 5-year relative survival rates appeared to be higher for most major cancers in patients diagnosed during 2006-2010 compared with those diagnosed during 1993-1995, with the exception of pancreatic cancer. The greatest improvements were seen in prostate cancer, stomach cancer, non-Hodgkin lymphoma, leukemia, and colorectal cancer. The improving survival rates could be attributable to early detection and improved treatments [19, 20], but this requires further evaluation. Only pancreatic cancer showed no improvement in 5-year relative survival rate compared with 1993-1995. A lack of progress in early detection and treatment could explain the observed absence of improvement in the survival rate for pancreatic cancer [21].
7. Prevalence rates
Table 10 shows the cancer prevalent rates on January 1, 2011 in Korea by sex and cancer site. The CRs of cancer prevalence for all sites combined were 1,739.0 and 2,113.4 per 100,000 in males and females, respectively, and the ASRs of cancer prevalence for all sites combined were 1,369.7 and 1,446.7 per 100,000 in males and females, respectively. In males, the five leading primary sites of cancer for prevalence were the stomach (CR, 451.7; ASR, 349.3), colon and rectum (CR, 323.2; ASR, 252.4), prostate (CR, 141.6; ASR, 114.1), liver (CR, 130.3; ASR, 100.1), and lung (CR, 115.2; ASR, 90.8), which together accounted for 66.8% of all prevalent cancer cases. In females, the most common cancer sites were the thyroid (CR, 596.9; ASR, 427.5), breast (CR, 413.4; ASR, 286.0), stomach (CR, 229.1; ASR, 144.6), colon and rectum (CR, 222.2; ASR, 138.7), cervix (CR, 154.6; ASR, 104.5), and lung (CR, 59.4; ASR, 37.4), which together accounted for 79.3% of all prevalent cancer cases.
Fig. 5 shows prevalence by time since diagnosis with cancer. For all cancers combined, the 1-2-year prevalence represented 33.0% of all prevalent cases. The 1-2-year prevalence, as a percentage of the total prevalence, was highest for thyroid cancer (21.4%), followed by stomach cancer (15.6%) and colorectal cancer (13.9%), which had high incidence rates and good prognoses. For all cancers combined, the 2-5-year and >5-year prevalences accounted for 31.6% and 35.4%, respectively, of the total prevalence in both sexes. The long-term prevalences of lung and liver cancers were relatively low due to their low survival rates.
Acknowledgements
This work was supported by a research grant from the National Cancer Center (no. 1310220), Republic of Korea. The authors are indebted to Korea Central Cancer Registry (KCCR)-affiliated hospitals, non-KCCR-affiliated hospitals, 11 regional cancer registries (the Busan, Daegu & Gyeongbuk, Gwangju & Jeonnam, Incheon, Daejeon & Chungnam, Ulsan, Gangwon, Chungbuk, Jeonbuk, Gyeongnam and Jejudo cancer registries), the National Health Insurance Corporation and Statistics Korea for data collection.

Conflict of interest relevant to this article was not reported.

  • 1. Statistics Korea [Internet]. 2012. cited 2013 Jan 4Daejeon: Statistics Korea; Available from: http://kostat.go.kr
  • 2. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, et al. Measuring the burden of disease in Korea. J Korean Med Sci. 2007;22:518–523. PMID: 17596664ArticlePubMedPMC
  • 3. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012;44:11–24. PMID: 22500156ArticlePubMedPMCPDF
  • 4. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122–131. PMID: 19809561ArticlePubMedPMCPDF
  • 5. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–331. PMID: 19956367ArticlePubMedPMCPDF
  • 6. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–1017. PMID: 9893469PubMed
  • 7. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 2000. 3rd ed. Geneva: World Health Organization.
  • 8. World Health OrganizationInternational statistical classification of diseases and related health problems. 1994. 10th rev. Geneva: World Health Organization.
  • 9. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). 1960. Sendai: Tohoku University School of Medicine.
  • 10. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007. 2010. Bethesda, MD: National Cancer Institute.
  • 11. National Cancer InstituteSEER*Stat Program, version 6.6.1 [Internet]. cited 2013 Jan 4Bethesda, MD: U. S. National Cancer Institute; Available from: http://seer.cancer.gov/seerstat/2010
  • 12. Ederer F, Heise H. Instructions to IBM programmers in processing survival computations. Methodological note No. 10. 1959. Bethesda, MD: National Cancer Institute.
  • 13. Paul Dickman [Internet]. cited 2010 Apr 14Stockholm: PaulDickman.com; Available from: http://www.pauldickman.com
  • 14. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–2167. PMID: 16684987ArticlePubMed
  • 15. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18:784–791. PMID: 19240234ArticlePubMedPMC
  • 16. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011;12:1657–1663. PMID: 22126540PubMed
  • 17. Kim SY. Study to provide evidence of health screening service for thyroid cancer. 2012. cited 2013 Jan 4Seoul: National Evidence based Healthcare Collaborating Agency; Available from: http://www.neca.re.kr/
  • 18. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. 2007. Vol. 9. Lyon: IARC Press.
  • 19. Jung KW, Yim SH, Kong HJ, Hwang SY, Won YJ, Lee JK, et al. Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci. 2007;22(Suppl):S5–S10. PMID: 17923755ArticlePubMedPMC
  • 20. Gondos A, Bray F, Hakulinen T, Brenner H. EUNICE Survival Working GroupTrends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009;20:564–573. PMID: 19066327ArticlePubMed
  • 21. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103–117. PMID: 16882274ArticlePubMed
Fig. 1
Annual age-standardized cancer incidence and death rates for all sites during 1983-2010 in Korea by sex. Age standardization was based on the world standard population.
crt-45-1-g001.jpg
Fig. 2
Trends in age-standardized incidences of selected cancers during 1999-2010 in Korea by sex. Age standardization was based on the world standard population. (A) Male. (B) Female.
crt-45-1-g002.jpg
Fig. 3
Age-specific incidence rates of major cancers during 2010 in Korea. (A) Male. (B) Female.
crt-45-1-g003.jpg
Fig. 4
Annual age-standardized mortalities of selected cancers during 1983-2010 in Korea by sex. Age standardization was based on the world standard population. (A) Male. (B) Female.
crt-45-1-g004.jpg
Fig. 5
Numbers of prevalent cases for major cancer sites on January 1, 2011 in Korea by time since diagnosis.
crt-45-1-g005.jpg
Table 1
Numbers of incident cancer cases, deaths, and prevalent cancer cases during 2010 in Korea by sex
Site/Type New cases
Deaths
Prevalent casesa)
Both Male Female Both Male Female Both Male Female
All sites 202,053 103,014 99,039 72,046 45,209 26,837 960,654 434,365 526,289
Lip, oral cavity and pharynx 2,695 1,916 779 963 742 221 13,961 9,464 4,497
Esophagus 2,199 2,017 182 1,352 1,254 98 6,303 5,689 614
Stomach 30,092 20,179 9,913 10,032 6,512 3,520 169,868 112,811 57,057
Colon and rectum 25,782 15,612 10,170 7,645 4,322 3,323 136,055 80,717 55,338
Liver 15,921 11,818 4,103 11,205 8,350 2,855 43,351 32,542 10,809
Gallbladderb) 4,877 2,532 2,345 3,502 1,758 1,744 12,349 6,337 6,012
Pancreas 4,637 2,505 2,132 4,306 2,323 1,983 5,583 3,052 2,531
Larynx 1,144 1,071 73 416 383 33 7,583 7,120 463
Lung 20,711 14,650 6,061 15,623 11,416 4,207 43,564 28,784 14,780
Breast 14,277 69 14,208 1,868 10 1,858 103,418 472 102,946
Cervix uteri 3,857 - 3,857 956 - 956 38,488 - 38,488
Corpus uteri 1,752 - 1,752 222 - 222 11,935 - 11,935
Ovary 1,981 - 1,981 895 - 895 11,782 - 11,782
Prostate 7,848 7,848 - 1,328 1,328 - 35,372 35,372 -
Testis 206 206 - 9 9 - 1,774 1,774 -
Kidney 3,598 2,520 1,078 797 562 235 20,203 13,639 6,564
Bladder 3,415 2,752 663 1,100 822 278 21,921 17,823 4,098
Brain and CNS 1,715 922 793 1,182 645 537 7,527 3,951 3,576
Thyroid 36,021 6,231 29,790 356 94 262 174,918 26,264 148,654
Hodgkin lymphoma 243 167 76 48 30 18 1,609 1,035 574
Non-Hodgkin lymphoma 3,940 2,171 1,769 1,457 817 640 20,838 11,394 9,444
Multiple myeloma 1,070 563 507 763 399 364 3,073 1,624 1,449
Leukemia 2,684 1,540 1,144 1,618 922 696 12,287 6,793 5,494
Other and ill-defined 11,388 5,725 5,663 4,403 2,511 1,892 56,892 27,708 29,184

CNS, central nervous system. a)Limited-duration prevalent cases on January 1, 2011. These are patients who were diagnosed between January 1, 1999 and December 31, 2010 and who were known alive on January 1, 2011. Multiple primary cancer cases were counted multiple times, b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 2
Crude and age-standardized cancer incidence rates during 2010 in Korea by sex
Site/Type Crude incidence rate per 100,000
Age-standardized incidence rate
per 100,000a)
Both Male Female Both Male Female
All sites 405.1 412.4 397.7 286.4 324.1 268.7
Lip, oral cavity, and pharynx 5.4 7.7 3.1 3.9 5.9 2.1
Esophagus 4.4 8.1 0.7 3.1 6.4 0.4
Stomach 60.3 80.8 39.8 41.8 62.3 24.9
Colon and rectum 51.7 62.5 40.8 35.9 48.6 25.3
Liver 31.9 47.3 16.5 22.3 36.0 10.2
Gallbladderb) 9.8 10.1 9.4 6.5 8.1 5.4
Pancreas 9.3 10.0 8.6 6.3 7.9 4.9
Larynx 2.3 4.3 0.3 1.6 3.4 0.2
Lung 41.5 58.7 24.3 28.0 46.5 14.3
Breast 28.6 0.3 57.1 20.2 0.2 39.8
Cervix uteri 7.7 - 15.5 5.5 - 10.6
Corpus uteri 3.5 - 7.0 2.5 - 5.0
Ovary 4.0 - 8.0 2.9 - 5.7
Prostate 15.7 31.4 - 10.7 25.3 -
Testis 0.4 0.8 - 0.4 0.8 -
Kidney 7.2 10.1 4.3 5.2 7.8 3.0
Bladder 6.8 11.0 2.7 4.6 8.7 1.5
Brain and CNS 3.4 3.7 3.2 3.0 3.4 2.6
Thyroid 72.2 24.9 119.6 52.7 18.3 87.4
Hodgkin lymphoma 0.5 0.7 0.3 0.4 0.6 0.3
Non-Hodgkin lymphoma 7.9 8.7 7.1 6.0 7.1 5.0
Multiple myeloma 2.1 2.3 2.0 1.5 1.7 1.3
Leukemia 5.4 6.2 4.6 5.0 6.0 4.1
Other and ill-defined 22.8 22.9 22.7 16.7 19.0 14.9

CNS, central nervous system. a)Age-adjusted using the world standard population, b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 3
The 10 leading causes of death in Korea during 2010
The 10 leading causes of death in Korea during 2010
Rank Cause of death No. of deaths Deaths (%) Age-standardized death rate
per 100,000a)
All causes 255,405 100.0 344.8
1 Cancer 69,780 28.2 96.3
2 Cerebrovascular disease 25,838 10.4 33.3
3 Heart disease 22,347 9.2 30.1
4 Intentional self-harm (suicide) 15,413 6.1 23.4
5 Diabetes mellitus 9,757 4.1 13.1
6 Pneumonia 7,147 2.9 9.4
7 Chronic lower respiratory diseases 6,914 2.8 8.7
8 Disease of the liver 6,868 2.7 9.5
9 Transport accidents 6,324 2.7 10.8
10 Hypertensive diseases 4,749 1.9 6.0
Others 74,485 29.2 104.3

Source: Mortality data, 2010, Statistics Korea [1]. a)Age-adjusted using the world standard population.

Table 4
Crude and age-standardized cancer mortality rates during 2010 in Korea by sex
Site/Type Crude mortality rate per 100,000
Age-standardized mortality rate
per 100,000a)
Both Male Female Both Male Female
All sites 144.4 181.0 107.8 96.3 144.7 61.6
Lip, oral cavity, and pharynx 1.9 3.0 0.9 1.3 2.3 0.5
Esophagus 2.7 5.0 0.4 1.8 4.0 0.2
Stomach 20.1 26.1 14.1 13.2 20.7 7.8
Colon and rectum 15.3 17.3 13.3 10.1 14.0 7.3
Liver 22.5 33.4 11.5 15.4 25.8 6.6
Gallbladderb) 7.0 7.0 7.0 4.5 5.7 3.7
Pancreas 8.6 9.3 8.0 5.7 7.4 4.4
Larynx 0.8 1.5 0.1 0.5 1.2 0.1
Lung 31.3 45.7 16.9 20.5 36.6 9.1
Breast 3.7 0.0 7.5 2.6 0.0 5.0
Cervix uteri 1.9 - 3.8 1.3 - 2.3
Corpus uteri 0.4 - 0.9 0.3 - 0.6
Ovary 1.8 - 3.6 1.2 - 2.3
Prostate 2.7 5.3 - 1.6 4.6 -
Testis 0.0 0.0 - 0.0 0.0 -
Kidney 1.6 2.3 0.9 1.1 1.8 0.5
Bladder 2.2 3.3 1.1 1.4 2.8 0.5
Brain and CNS 2.4 2.6 2.2 1.8 2.2 1.4
Thyroid 0.7 0.4 1.1 0.5 0.3 0.5
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 2.9 3.3 2.6 2.0 2.6 1.5
Multiple myeloma 1.5 1.6 1.5 1.0 1.3 0.8
Leukemia 3.2 3.7 2.8 2.5 3.1 1.9
Other and ill-defined 8.8 10.1 7.6 6.0 8.2 4.4

CNS, central nervous system. a)Age-adjusted using the world standard population, b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 5
Trends in cancer incidence rates in both sexes during 1999-2010 in Korea
Site/Type Year
APC
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
All sites 210.5 205.1 216.7 220.1 227.4 234.5 247.3 251.4 262.3 274.5 284.6 286.4 3.3a)
Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.8 3.9 0.2
Esophagus 4.1 3.7 3.9 3.8 3.6 3.5 3.5 3.4 3.3 3.3 3.1 3.1 -2.2a)
Stomach 43.6 42.3 44.0 43.6 43.2 41.1 44.4 42.8 41.7 42.5 43.3 41.8 -0.2
Colon and rectum 20.4 21.0 22.9 24.7 26.8 28.6 30.9 32.4 33.6 34.6 36.6 35.9 5.9a)
Liver 27.9 26.7 27.3 26.5 25.7 25.6 25.8 24.5 24.3 24.0 23.4 22.3 -1.8a)
Gallbladderb) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.6 6.4 6.7 6.5 0.0
Pancreas 5.6 5.5 5.5 5.8 5.9 6.0 6.3 6.2 6.3 6.4 6.3 6.3 1.4a)
Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.6 1.7 1.6 -3.6a)
Lung 28.5 27.7 28.3 28.5 27.9 28.8 28.9 28.7 28.4 28.1 28.1 28.0 0.0
Breast 10.7 10.8 12.7 13.9 14.2 14.9 16.2 16.9 18.0 18.8 19.5 20.2 6.1a)
Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.7 5.9 5.5 5.5 -4.3a)
Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 2.4 2.6 2.5 6.0a)
Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.0 2.9 2.7 2.9 1.3a)
Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.3 8.6 9.7 10.5 10.7 14.3a)
Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 4.0a)
Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.0 5.2 5.2 6.1a)
Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.5 4.6 -0.1
Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.0 3.0 3.0 0.8a)
Thyroid 6.3 6.1 7.9 9.5 12.8 17.2 20.7 25.4 32.8 41.3 47.9 52.7 24.2a)
Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 4.6a)
Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 4.9 5.3 5.3 5.5 5.5 5.6 6.1 6.0 3.3a)
Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 1.5 4.0a)
Leukemia 4.7 4.3 4.7 4.8 4.8 4.8 4.7 4.9 4.8 5.0 5.0 5.0 0.9a)
Other and ill-defined 14.3 13.5 13.9 13.5 15.1 15.2 16.1 16.0 17.0 16.9 16.8 16.7 -

APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the world standard population. a)Significantly different from zero (p<0.05), b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 6
Trends in cancer incidence rates in males during 1999-2010 in Korea
Site/Type Year
APC
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
All sites 285.0 276.7 288.3 290.0 294.6 299.2 311.0 309.6 315.8 322.5 328.3 324.1 1.5a)
Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.2 6.1 6.1 6.3 6.5 6.1 5.9 -0.5
Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 6.9 7.0 6.6 6.4 -2.6a)
Stomach 66.2 65.0 67.2 66.6 65.9 62.3 66.9 65.3 63.0 64.3 64.8 62.3 -0.4a)
Colon and rectum 26.2 27.2 29.6 32.9 35.3 37.9 41.1 43.2 45.2 46.7 49.6 48.6 6.4a)
Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.2 39.7 39.3 38.0 36.0 -2.1a)
Gallbladderb) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.0 8.1 -0.1
Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.4 8.1 7.9 0.6a)
Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.7 3.8 3.5 3.6 3.4 -3.6a)
Lung 51.4 49.8 51.1 51.0 49.9 50.8 50.8 49.2 48.7 47.5 47.3 46.5 -0.8a)
Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 -1.6
Prostate 8.4 7.2 9.5 10.1 12.4 15.1 15.7 17.9 20.8 23.4 24.9 25.3 12.8a)
Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 3.9a)
Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.0 7.4 7.6 7.8 5.8a)
Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.4 9.1 8.6 8.7 -0.3
Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.1 3.4 3.4 3.4 3.4 1.0a)
Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.3 15.5 18.3 24.8a)
Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.6 3.7a)
Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.5 6.9 7.0 6.8 7.4 7.1 2.5a)
Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.5 1.6 1.7 1.9 1.7 3.4a)
Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.6 5.6 5.7 5.8 5.9 6.0 1.0a)
Other and ill-defined 17.9 16.5 16.8 16.5 18.4 18.2 19.2 18.7 20.1 19.6 19.7 19.0 -

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system. a)Significantly different from zero (p<0.05), b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 7
Trends in cancer incidence rates in females during 1999-2010 in Korea
Site/Type Year
APC
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
All sites 161.1 157.4 169.0 174.6 184.1 193.1 207.3 215.9 231.2 248.3 261.8 268.7 5.3a)
Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 2.1 1.0
Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 0.4 -2.8a)
Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.0 24.7 25.1 25.6 24.9 -0.4
Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.5 22.9 24.0 24.5 25.0 26.1 25.3 4.7a)
Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.4 11.1 11.1 10.6 10.6 10.2 -1.6a)
Gallbladderb) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.8 5.4 0.0
Pancreas 4.0 4.0 4.0 4.2 4.5 4.5 4.7 4.7 4.7 4.9 4.8 4.9 2.2a)
Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 -7.7a)
Lung 12.4 12.5 12.3 2.6 12.4 13.0 13.5 14.0 13.9 14.1 14.0 14.3 1.6a)
Breast 20.9 20.9 24.7 27.2 27.8 29.2 31.8 33.2 35.5 37.0 38.5 39.8 6.3a)
Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.1 12.3 12.2 11.0 11.4 10.6 10.6 -4.2a)
Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.1 5.0 6.2a)
Ovary 5.0 4.8 4.8 5.0 5.1 5.2 5.4 5.4 5.9 5.6 5.3 5.7 1.6a)
Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.2 3.0 6.0a)
Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.6 1.5 -0.7
Brain and CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.6 2.8 2.6 2.5 2.6 0.5
Thyroid 10.4 10.1 13.2 16.2 21.8 29.5 35.3 43.2 55.5 69.3 80.4 87.4 24.2a)
Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 5.9a)
Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.4 4.4 4.3 4.7 5.0 5.0 4.3a)
Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.3 4.7a)
Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.2 4.3 4.2 4.1 0.7a)
Other and ill-defined 11.8 11.5 11.8 11.5 12.7 13.0 13.8 14.0 14.6 14.8 14.6 14.9 -

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system. a)Significantly different from zero (p<0.05), b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 8
The five major sites of cancer incidence during 2010 in Korea by age group and sex
Rank Age (yr)
0-14 15-34 35-64 ≥65
Male
1 Leukemia Thyroid Stomach Lung
(5.1) (11.2) (95.2) (455.0)
2 Brain and CNS Leukemia Colon and rectum Stomach
(2.5) (3.1) (72.1) (433.2)
3 Non-Hodgkin lymphoma Colon and rectum Liver Colon and rectum
(2.0) (2.7) (66.4) (340.6)
4 Kidney Non-Hodgkin lymphoma Thyroid Prostate
(0.5) (2.6) (42.9) (274.1)
5 Testis Stomach Lung Liver
(0.3) (2.6) (42.5) (199.3)
Female
1 Leukemia Thyroid Thyroid Colon and rectum
(3.6) (59.9) (209.8) (175.7)
2 Brain and CNS Breast Breast Stomach
(1.7) (10.0) (106.5) (162.2)
3 Ovary Cervix uteri Stomach Lung
(0.8) (5.6) (40.8) (121.5)
4 Thyroid Stomach Colon and rectum Thyroid
(0.7) (4.3) (40.5) (85.0)
5 Non-Hodgkin lymphoma Ovary Cervix uteri Liver
(0.6) (3.0) (23.0) (77.8)

CNS, central nervous system.

Table 9
Trends in the 5-year relative survival rates (%) during 1993-2010 in Korea by year of diagnosis
Site/Type Both
Male
Female
1993-1995 1996-2000 2001-2005 2006-2010 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 Changea)
All sites 41.2 44.0 53.7 64.1 22.9 31.7 35.3 45.2 55.4 23.7 53.4 55.3 63.9 73.3 19.9
Lip, oral cavity, and pharynx 41.1 46.7 54.1 60.1 19.0 35.8 41.1 49.3 56.3 20.5 58.1 63.8 67.7 70.2 12.1
Esophagus 12.7 15.2 21.1 29.4 16.7 11.8 14.3 20.4 28.7 16.9 23.7 24.2 29.5 36.8 13.1
Stomach 42.8 46.6 57.7 67.0 24.2 43.0 46.9 58.4 67.7 24.7 42.6 46.0 56.3 65.7 23.1
Colon and rectum 54.8 58.0 66.6 72.6 17.8 55.3 59.0 68.5 74.5 19.2 54.2 56.8 64.1 69.9 15.7
Liver 10.7 13.2 20.1 26.7 16.0 9.9 12.9 20.1 26.7 16.8 13.6 14.2 20.3 26.8 13.2
Gallbladderb) 17.3 19.7 22.8 26.7 9.4 16.6 20.3 23.3 27.9 11.3 18.0 19.1 22.3 25.5 7.5
Pancreas 9.4 7.6 8.0 8.0 -1.4 8.8 7.3 8.0 7.7 -1.1 10.1 8.1 8.1 8.3 -1.8
Larynx 59.7 62.3 66.1 72.3 12.6 60.2 62.8 66.7 72.7 12.5 55.4 57.8 58.2 66.0 10.6
Lung 11.3 12.7 16.2 19.7 8.4 10.4 11.6 14.9 17.5 7.1 14.2 16.2 19.7 25.4 11.2
Breast 77.9 83.2 88.5 91.0 13.1 75.1 85.6 87.0 89.6 14.5 78.0 83.2 88.5 91.0 13.0
Cervix uteri 77.5 80.0 81.2 80.2 2.7 - - - - - 77.5 80.0 81.2 80.2 2.7
Corpus uteri 81.5 81.8 84.6 86.2 4.7 - - - - - 81.5 81.8 84.6 86.2 4.7
Ovary 58.7 58.9 61.3 60.4 1.7 - - - - - 58.7 58.9 61.3 60.4 1.7
Prostate 55.9 67.2 80.1 90.2 34.3 55.9 67.2 80.1 90.2 34.3 - - - - -
Testis 85.4 90.4 90.6 92.5 7.1 85.4 90.4 90.6 92.5 7.1 - - - - -
Kidney 62.0 66.1 73.3 77.7 15.7 60.8 64.4 72.8 77.7 16.9 64.5 69.7 74.4 77.8 13.3
Bladder 69.1 73.1 75.5 76.3 7.2 70.0 74.8 77.3 78.3 8.3 65.5 66.3 68.5 68.4 2.9
Brain and CNS 38.5 39.0 40.5 42.6 4.1 37.2 37.5 39.9 41.4 4.2 40.2 40.7 41.2 44.0 3.8
Thyroid 94.2 94.9 98.3 99.8 5.6 87.2 89.5 95.8 99.8 12.6 95.4 95.9 98.7 99.7 4.3
Hodgkin lymphoma 68.0 71.2 76.7 80.8 12.8 67.6 68.1 74.7 80.4 12.8 68.6 77.4 80.6 81.4 12.8
Non-Hodgkin lymphoma 46.6 50.8 59.9 64.9 18.3 45.3 48.9 58.0 63.2 17.9 48.7 53.5 62.3 67.0 18.3
Multiple myeloma 22.1 19.8 29.2 35.1 13.0 21.1 17.8 29.5 35.3 14.2 23.3 22.1 28.9 34.9 11.6
Leukemia 26.5 33.3 41.8 47.2 20.7 26.2 32.3 41.6 46.2 20.0 26.8 34.6 41.9 48.4 21.6
Other and ill-defined 42.1 45.9 55.6 64.2 22.1 37.4 42.4 52.0 60.4 23.0 47.4 50.0 59.6 68.1 20.7

CNS, central nervous system. a)Change in 5-year relative survival between 1993-1995 and 2006-2010 as a percentage. b)Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 10
Crude and age-standardized rates of cancer prevalence on January 1, 2011 in Korea by sex
Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalenc rate
per 100,000b)
Both Male Female Both Male Female
All sites 1925.9 1739.0 2113.4 1370.9 1369.7 1446.7
Lip, oral cavity, and pharynx 28.0 37.9 18.1 20.2 29.3 12.4
Esophagus 12.6 22.8 2.5 8.8 18.0 1.5
Stomach 340.6 451.7 229.1 236.4 349.3 144.6
Colon and rectum 272.8 323.2 222.2 188.8 252.4 138.7
Liver 86.9 130.3 43.4 62.5 100.1 28.9
Gallbladderc) 24.8 25.4 24.1 16.9 20.0 14.6
Pancreas 11.2 12.2 10.2 7.8 9.6 6.4
Larynx 15.2 28.5 1.9 10.6 22.6 1.1
Lung 87.3 115.2 59.4 60.5 90.8 37.4
Breast 207.3 1.9 413.4 145.8 1.5 286.0
Cervix uteri 77.2 - 154.6 53.9 - 104.5
Corpus uteri 23.9 - 47.9 17.2 - 33.7
Ovary 23.6 - 47.3 17.7 - 34.9
Prostate 70.9 141.6 - 46.5 114.1 -
Testis 3.6 7.1 - 3.3 6.4 -
Kidney 40.5 54.6 26.4 29.5 42.3 18.4
Bladder 43.9 71.4 16.5 29.5 56.5 9.4
Brain and CNS 15.1 15.8 14.4 13.5 14.5 12.5
Thyroid 350.7 105.2 596.9 253.0 76.9 427.5
Hodgkin lymphoma 3.2 4.1 2.3 2.8 3.5 2.0
Non-Hodgkin lymphoma 41.8 45.6 37.9 31.9 37.1 27.5
Multiple myeloma 6.2 6.5 5.8 4.4 5.0 3.8
Leukemia 24.6 27.2 22.1 24.2 27.0 21.5
Other and ill-defined 114.1 110.9 117.2 85.1 92.6 79.2

CNS, central nervous system. a)Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2010 and who were alive on January 1, 2011. Multiple primary cancer cases were counted multiple times, b)Age-adjusted using the world standard population, c)Includes the gallbladder and other/unspecified parts of the biliary tract.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Factors Influencing Postoperative Quality of Life in Korean Brain Tumor Survivors
      Soomin Lim, Smi Choi-Kwon
      Journal of Neuroscience Nursing.2025;[Epub]     CrossRef
    • Morphological Complexity of Intrapapillary Capillary Loops for Predicting the Invasion Depth of Superficial Esophageal Neoplasms Using Narrow‐Band Imaging
      Jeongeun Hwang, Hyungchul Park, Jooyoung Park, Do Hoon Kim, Namkug Kim
      International Journal of Imaging Systems and Technology.2024;[Epub]     CrossRef
    • Perspectives on delivering sexual and reproductive health and rights information and services to young people: focus group discussions with civil society organizations in the Democratic Republic of Congo
      Landry Egbende, Viviane Mayala, Branly Mbunga, Nina Viberg, Mala Ali Mapatano, Tobias Alfvén, Eva Åkerman
      Global Health Action.2024;[Epub]     CrossRef
    • Risks of Leukemia in Various Industrial Groups in Korea: A Retrospective National Cohort Study
      Won-Tae Lee, Woo-Ri Lee, Wanhyung Lee, Jin-Ha Yoon, Jongin Lee
      International Journal of Environmental Research and Public Health.2023; 20(2): 1187.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Sex‐specific differences in colorectal cancer: A multicenter retrospective cohort study
      Hyun Jin Joo, Hyun Seok Lee, Byung Ik Jang, Dae Bum Kim, Jae Hyun Kim, Jae Jun Park, Hyun Gun Kim, Il Hyun Baek, Jun Lee, Bun Kim
      Cancer Reports.2023;[Epub]     CrossRef
    • Mental Disorders and Suicide Risk among Cancer Patients: A Nationwide Cohort Study
      Jae Woo Choi, Eun-Cheol Park, Tae Hyun Kim, Euna Han
      Archives of Suicide Research.2022; 26(1): 44.     CrossRef
    • Impact of loss of skeletal muscle mass within 6–12 months after gastrectomy and S1 adjuvant chemotherapy on the survival prognosis of elderly patients with gastric cancer
      Shiro Fujihata, Shinichi Sakuramoto, Yosuke Morimoto, Kazuaki Matsui, Keiji Nishibeppu, Gen Ebara, Shohei Fujita, Shuichiro Oya, Hirofumi Sugita, Seigi Lee, Yutaka Miyawaki, Hiroshi Sato, Shuji Takiguchi, Keishi Yamashita
      Surgery Today.2022; 52(10): 1472.     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Bioelectrical impedance spectroscopy can assist to identify the parathyroid gland during thyroid surgery
      Bin Wang, Zaoyang Liu, Jian Wu, Ying Liu, Pin Wang, Hong Liu, Haobin Wang, Tielin Wang, Juan Wang, Yan Tang, Junyan Zhang
      Frontiers in Endocrinology.2022;[Epub]     CrossRef
    • Is 99m Technetium (Pertechnetate) More Efficient in Clinical Evaluation of Thyroid Lesions Compared to 123 Iodine? A Scoping Review
      Magbool Alelyani, Mohammed Alshehri, Nasser Shubayr, Yazeed Alashban, Abulaziz Alshihri
      King Khalid University Journal of Health Sciences.2022; 7(2): 77.     CrossRef
    • High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study
      Jayoun Lee, Songhee Cho, Hyo Jeong Kim, Hangil Lee, Min Jung Ko, Young‐Suk Lim
      Journal of Viral Hepatitis.2021; 28(2): 353.     CrossRef
    • Cancer Incidence and Survival among Adolescents and Young Adults in Korea: An Update for 2016
      Meerim Park, Jiwon Lim, Jun Ah Lee, Byung Kiu Park, Kyu-Won Jung, Young-Joo Won, Hyeon Jin Park
      Cancer Research and Treatment.2021; 53(1): 32.     CrossRef
    • Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study
      Joon Ho, Eunhwa Kim, Minkyung Han, Inkyung Jung, Jandee Lee, Young Suk Jo
      Annals of Surgical Oncology.2021; 28(8): 4373.     CrossRef
    • Pertencimento à classe social e práticas corporais: revisando o tema na literatura e ensaiando relações possíveis
      Breno Brey D'auria, Cristiano Mezzaroba, Silvan Menezes dos Santos
      Podium Sport Leisure and Tourism Review.2021; 10(2): 54.     CrossRef
    • More than 10-years survival despite bilateral breast cancer and multiple bone metastasis: a case report
      Fadi Mikhael
      SSRN Electronic Journal .2021;[Epub]     CrossRef
    • Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer
      Taejong Song, Seok Ju Seong, Seon-Kyung Lee, Byoung-Ryun Kim, Woong Ju, Ki Hyung Kim, Kyehyun Nam, Jae Chul Sim, Tae Jin Kim
      Journal of Obstetrics and Gynaecology.2020; 40(2): 240.     CrossRef
    • BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer
      Kai Li, Wen-ting Pan, Yan-bin Ma, Xiao-long Xu, Yang Gao, Yan-qi He, Lei Wei, Jing-wei Zhang
      Breast Cancer.2020; 27(3): 363.     CrossRef
    • Objectively measured physical activity during chemotherapy in colon cancer patients
      Hyuna Park, Minkyu Jung, Min Jae Kim, Jihee Min, Choong-Kun Lee, Sang Joon Shin, Seung-Hoon Beom, Joong Bae Ahn, Justin Y. Jeon
      Supportive Care in Cancer.2020; 28(6): 2597.     CrossRef
    • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
      Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
      Annals of Global Health.2020; 86(1): 2.     CrossRef
    • Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma
      Md. Ali Hossain, Tania Akter Asa, Md. Mijanur Rahman, Shahadat Uddin, Ahmed A. Moustafa, Julian M. W. Quinn, Mohammad Ali Moni
      International Journal of Environmental Research and Public Health.2020; 17(4): 1373.     CrossRef
    • Long noncoding RNAs as diagnostic biomarkers for the early detection of digestive tract cancers: a systematic review and meta-analysis
      Yinghui Yu, Yinlong Zhao, Chunpeng Wang, Xueyuan Zhang, Xin Liu
      Revista Española de Enfermedades Digestivas.2020;[Epub]     CrossRef
    • Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality
      Jie-Hyun Kim, Kyung-Do Han, Jung Kuk Lee, Hyun-Soo Kim, Jae Myung Cha, Sohee Park, Joo Sung Kim, Won Ho Kim
      British Journal of Cancer.2020; 123(3): 480.     CrossRef
    • Thyroid Cancer Patients’ Interests and Information Seeking Behavior: Focused on Online Community Analysis
      Kyung Ah Park, Sanghee Kim, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park
      International Journal of Thyroidology.2020; 13(1): 30.     CrossRef
    • A Conditional Probability Model to Predict the Mortality in Patients With Breast Cancer: A Bayesian Network Analysis
      Zeynab Iraji, Mohammad Asghari Jafarabadi, Tohid Jafari-Koshki, Roya Dolatkhah
      The American Journal of the Medical Sciences.2020; 360(5): 575.     CrossRef
    • Factors affecting online health community participation behavior in patients with thyroid cancer
      Kyung Ah Park, So Yeon Eum, Hyeonjung Oh, Myung Hae Cho, Hang-Seok Chang, Yong Sang Lee, Sanghee Kim, Cheong Soo Park, Michio Murakami
      PLOS ONE.2020; 15(6): e0235056.     CrossRef
    • Liver X Receptor β Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer
      Seonhyang Jeong, In-Kyu Kim, Hyunji Kim, Moon Jung Choi, Jandee Lee, Young Suk Jo
      Endocrinology and Metabolism.2020; 35(3): 656.     CrossRef
    • Relationships of Symptom Groups and Functioning Domains in Patients with Advanced-Stage Non-Small Cell Lung Cancer Undergoing Treatment: A Cross-Sectional Study
      Myung Kyung Lee
      Healthcare.2020; 9(1): 28.     CrossRef
    • Relevance of nationwide prostate specific antigen screening test for prostate cancer
      Young Hwii Ko, Young Goo Lee
      Journal of the Korean Medical Association.2020; 63(11): 652.     CrossRef
    • Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis
      Lan Thi Hanh Phi, Ita Novita Sari, Yoseph Toni Wijaya, Kwang Seock Kim, Kichul Park, Art E. Cho, Hyog Young Kwon
      IUBMB Life.2019; 71(5): 601.     CrossRef
    • Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia
      Taejong Song, Seok Ju Seong, Seon-Kyung Lee, Byoung-Ryun Kim, Woong Ju, Ki Hyung Kim, Kyehyun Nam, Jae Chul Sim, Tae Jin Kim
      European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 234: 112.     CrossRef
    • Critical evaluation of the use of total reflection X-ray fluorescence spectrometry for the analysis of whole blood samples: application to patients with thyroid gland diseases
      Eva Marguí, Jasna Jablan, Marko Gerić, Suzana Inić, Ana-Marija Domijan, Renato Janušić, Božena Šarčević, Ignasi Queralt, Verica Garaj-Vrhovac
      Analytical and Bioanalytical Chemistry.2019; 411(8): 1659.     CrossRef
    • National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database
      Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim
      BMC Health Services Research.2019;[Epub]     CrossRef
    • The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: A meta-analysis
      Bin Wang, Chun-Rong Zhu, Hong Liu, Jian Wu, Biniam Kidane
      PLOS ONE.2019; 14(8): e0221173.     CrossRef
    • Clinical Value of Lymph Node Ratio Integration with the 8th Edition of the UICC TNM Classification and 2015 ATA Risk Stratification Systems for Recurrence Prediction in Papillary Thyroid Cancer
      Jandee Lee, Seul Gi Lee, Kwangsoon Kim, Seung Hyuk Yim, Haengrang Ryu, Cho Rok Lee, Sang Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Young Suk Jo
      Scientific Reports.2019;[Epub]     CrossRef
    • Role of a noninvasive stool-based molecular test in screening and early detection of colorectal cancers
      KhalidAhmad Al-Sindi, MulazimHussain Bukhari, MohmedAli Al-Hamar
      Acta Medica International.2019; 6(2): 82.     CrossRef
    • The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus
      Ho Seok Seo, Yoon Ju Jung, Ji Hyun Kim, Han Hong Lee, Cho Hyun Park
      American Journal of Clinical Oncology.2019; 42(12): 909.     CrossRef
    • Postthyroidectomy obesity in a Korean population: does the extent of surgery matter?
      Min-Young Park, Sang Eun Nam, Kyoung Sik Park, Madhuri Saindane, Young-Bum Yoo, Jung-Hyun Yang, Ah-Leum Ahn, Jae-Kyung Choi, Won Seo Park
      Annals of Surgical Treatment and Research.2019; 97(3): 119.     CrossRef
    • Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
      Meng Zhang, Shan Liu, Yue Hu, Hai-biao Bao, Li-na Meng, Xiao-teng Wang, Yi Xu, Jing Zhao, Bin Lu
      Scientific Reports.2019;[Epub]     CrossRef
    • BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
      Sung-Bae Kim, In-Gu Do, Janice Tsang, Tae-You Kim, Yoon-Sim Yap, Gerardo Cornelio, Gyungyub Gong, Soonmyung Paik, Suee Lee, Ting-Ying Ng, Sarah Park, Ho-Suk Oh, Joanne Chiu, Joohyuk Sohn, Moonhee Lee, Young-Jin Choi, Eun Mi Lee, Kyong-Hwa Park, Christos N
      Cancer Research and Treatment.2019; 51(4): 1527.     CrossRef
    • Factors Affecting Postoperative Occupational Changes and Sick Leave in Patients with Thyroid Cancer
      Kyung Ah Park, Young Ja Oh, Sang Hui Chu, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park
      International Journal of Thyroidology.2019; 12(2): 113.     CrossRef
    • Comparison of Natural Course between Thyroid Cancer Nodules and Thyroid Benign Nodules
      Kyun-Jin Yun, Jeonghoon Ha, Min-Hee Kim, Ye Young Seo, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek
      Endocrinology and Metabolism.2019; 34(2): 195.     CrossRef
    • Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma
      Nizhen Xu, Deguang Zhang, Jian Chen, Gaofei He, Li Gao
      Oncology Letters.2019;[Epub]     CrossRef
    • Obesity Factors (Physical Activity and Usual Dietary Pattern) and Breast Cancer in Korea
      Myeong Seong Kim, Young Hee Nam
      Polish Journal of Sport and Tourism.2019; 26(3): 29.     CrossRef
    • Social Media Use for Cancer Education at a Community-Based Cancer Center in South Korea
      Jaesung Heo, Mison Chun, Hyun Woo Lee, Jeong-Hee Woo
      Journal of Cancer Education.2018; 33(4): 769.     CrossRef
    • Korean Red Ginseng extract reduces hypoxia-induced epithelial-mesenchymal transition by repressing NF-κB and ERK1/2 pathways in colon cancer
      Eui Joo Kim, Kwang An Kwon, Young Eun Lee, Ju Hyun Kim, Se-Hee Kim, Jung Ho Kim
      Journal of Ginseng Research.2018; 42(3): 288.     CrossRef
    • A Comparison Study
      Yang Gyeong Yoo, Boas J. Yu, Eun-Hi Choi
      Cancer Nursing.2018; 41(1): E48.     CrossRef
    • Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis
      Young Jin Choi, Dae Hoon Kim, Hye Suk Han, Joung-Ho Han, Seung-Myoung Son, Dong Soo Kim, Hyo Yung Yun
      World Journal of Gastroenterology.2018; 24(1): 150.     CrossRef
    • Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic population
      Bo Hyun Kim, Young‐Suk Lim, Eun‐Yang Kim, Hyun‐Joo Kong, Young‐Joo Won, Seungbong Han, Sohee Park, Jae Seok Hwang
      Journal of Gastroenterology and Hepatology.2018; 33(2): 475.     CrossRef
    • Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study
      Mi Kyung Lee, Nam Kyu Kim, Justin Y. Jeon, Dongmei Li
      PLOS ONE.2018; 13(4): e0196220.     CrossRef
    • Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer
      Joon Ho Choi, Ilhan Lim, Woo Chul Noh, Hyun-Ah Kim, Min-Ki Seong, Seonah Jang, Hyesil Seol, Hansol Moon, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang Moo Lim
      Annals of Nuclear Medicine.2018; 32(6): 389.     CrossRef
    • Estimation of the medical need for carbon-ion radiotherapy in Korea
      Ilsung Cho, Young Seok Seo, WonGyun Jung, Mi-sook Kim
      Journal of Radiation Research.2018; 59(5): 588.     CrossRef
    • Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer
      D. M. Yagudaev, Z. A. Kadyrov, M. R. Kalinin, V. A. Bezhenar, N. A. Kalyagina
      Cancer Urology.2018; 14(2): 171.     CrossRef
    • Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer
      Jeong Il Yu, Do Hoon Lim, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Seung Tae Kim, Su Jin Lee, Sung Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Hye Seung Kim, Soohyun Ahn
      Radiotherapy and Oncology.2018; 129(2): 306.     CrossRef
    • Glycated Hemoglobin and Cancer Risk in Korean Adults: Results from Korean Genome and Epidemiology Study
      Ji Young Kim, Youn Sue Lee, Garam Jo, Min-Jeong Shin
      Clinical Nutrition Research.2018; 7(3): 170.     CrossRef
    • Differential relationship between waist circumference and mortality according to age, sex, and body mass index in Koreans with age of 30–90 years; a nationwide health insurance database study
      Geum Joon Cho, Hye Jin Yoo, Soon Young Hwang, Jun Choi, Kyu-Min Lee, Kyung Mook Choi, Sei Hyun Baik, Sung Won Han, Tak Kim
      BMC Medicine.2018;[Epub]     CrossRef
    • The function of carbon nanoparticles to improve lymph node dissection and identification of parathyroid glands during thyroid reoperation for carcinoma
      Bin Wang, An-Ping Su, Teng-Fei Xing, Han Luo, Wan-Jun Zhao, Jing-Qiang Zhu
      Medicine.2018; 97(32): e11778.     CrossRef
    • Is low cholesterol a risk factor for cancer mortality?
      Nader Parsa, Samira Taravatmanesh, Maurizio Trevisan
      European Journal of Cancer Prevention.2018; 27(6): 570.     CrossRef
    • Relationship between ultrasonographic and pathologic calcification patterns in papillary thyroid cancer
      Bu Kyung Kim, Eun Mi Lee, Jeong Hoon Kim, So Young Oak, Su Kyoung Kwon, Young Sik Choi, Young Ok Kim
      Medicine.2018; 97(41): e12675.     CrossRef
    • Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma
      Lihua Huang, Xuming Wang, Xuan Huang, Huawei Gui, Yan Li, Qiongxia Chen, Dongling Liu, Lijiang Liu
      Oncology Letters.2018;[Epub]     CrossRef
    • Treatment interruption during radiation therapy: Experience at a single institution in the Republic of Korea
      Jung Ae Lee, Nam Kwon Lee, Won Sup Yoon, Dae Sik Yang, Chul Yong Kim, Se Ryun Lee, Hwa Jeong Seong
      Asia-Pacific Journal of Clinical Oncology.2017;[Epub]     CrossRef
    • Outcomes of octogenarians undergoing gastrectomy performed for malignancy
      Annabelle Teng, Geoffrey Bellini, Erica Pettke, Michael Passeri, David Y. Lee, Keith Rose, Anton J. Bilchik, Fadi Attiyeh
      Journal of Surgical Research.2017; 207: 1.     CrossRef
    • Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials
      Seong-Hwan Chang, Soo-Nyung Kim, Hye Jung Choi, Misuk Park, Rock Bum Kim, Se-Il Go, Won Sup Lee
      Cancer Research and Treatment.2017; 49(1): 263.     CrossRef
    • Navigation programs, are they helpful for perioperative care with thyroid cancer patients?
      K.A. Park, Y.J. Oh, K.M. Kim, S.Y. Eum, M.H. Cho, Y.H. Son, S.H. Park, K.M. Woo, Y.S. Lee, S. Kim, H.-S. Chang, C.S. Park
      European Journal of Cancer Care.2017; 26(4): e12592.     CrossRef
    • Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis
      Jing Yu, Zhao-Juan Wang, Long-Hua Chen, Wen-Zhu Dong
      Scandinavian Journal of Clinical and Laboratory Investigation.2017; 77(1): 8.     CrossRef
    • Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
      Yo-Han Cho, So Young Yoon, Soo-Nyung Kim
      Cancer Research and Treatment.2017; 49(1): 255.     CrossRef
    • The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection
      Young Saing Kim, Chi-Young Jeong, Haa-Na Song, Tae Hyo Kim, Hong Jun Kim, Young-Joon Lee, Soon Chan Hong
      Chinese Journal of Cancer.2017;[Epub]     CrossRef
    • Treatment of radiation-induced cystitis and vulvodynia via a ganglion impar block using a lateral approach under computed tomography guidance: a case report
      Jeong-Eun Lee, Kyung-Hwa Kwak, Seong Wook Hong, Hoon Jung, Seung-Yeon Chung, Jun-Mo Park
      Korean Journal of Anesthesiology.2017; 70(1): 81.     CrossRef
    • Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia
      Seong Gu Heo, Youngil Koh, Jong Kwang Kim, Jongsun Jung, Hyung-Lae Kim, Sung-Soo Yoon, Ji Wan Park
      BMC Medical Genetics.2017;[Epub]     CrossRef
    • Epidemiological trend of pulmonary thromboembolism at a tertiary hospital in Korea
      Tae Yun Park, Jae-Woo Jung, Jae Chol Choi, Jong Wook Shin, Jae Yeol Kim, Byoung Whui Choi, In Won Park
      The Korean Journal of Internal Medicine.2017; 32(6): 1037.     CrossRef
    • A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis from Co-Occurring Prostate Cancer
      Miyeong Park, Sang-Ho Jeong, Young-Joon Lee, Ji-Ho Park, Sang-Kyung Choi, Soon-Chan Hong, Eun-Jung Jung, Young-tae Ju, Chi-Young Jeong, Jeong-Hee Lee, Woo-Song Ha
      Journal of Gastric Cancer.2017; 17(1): 93.     CrossRef
    • Clinical and pathological evaluation of patients with prostate and colorectal cancer five or more years after curative resection
      Jung Nam Lee, Yeon Ho Park, Jung Han, Jeong‐Heum Baek, Sung Won Park, Won‐Suk Lee
      Surgical Practice.2017; 21(2): 58.     CrossRef
    • Characteristics and outcomes of ALK+ non‐small cell lung cancer patients in Korea
      Sung Hee Lim, Kyung Ah Yoh, Jong Seok Lee, Myung‐ju Ahn, Yu Jung Kim, Se Hyun Kim, Jie Zhang, Dony Patel, Elyse Swallow, Andrew Kageleiry, Philip Galebach, Dongyeol Lee, Karen Stein, Ravi Degun, Keunchil Park
      Asia-Pacific Journal of Clinical Oncology.2017;[Epub]     CrossRef
    • Effects of a Mindfulness-Based Stress Reduction Program on the Physical and Psychological Status and Quality of Life in Patients With Metastatic Breast Cancer
      Chung Eun Lee, Sanghee Kim, Sue Kim, Hye Myung Joo, Soohyeon Lee
      Holistic Nursing Practice.2017; 31(4): 260.     CrossRef
    • Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma
      Cheol Lee, Bohyun Kim, Boram Song, Kyung Chul Moon
      Journal of Pathology and Translational Medicine.2017; 51(4): 359.     CrossRef
    • CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients
      Lin Yang, Shanshan Zou, Chang Shu, Yan Song, Yong-Kun Sun, Wen Zhang, Aiping Zhou, Xinghua Yuan, Yi Yang, Songnian Hu
      Genomics, Proteomics & Bioinformatics.2017; 15(4): 255.     CrossRef
    • The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression
      Thressi Maxwell, So-Young Chun, Kyu-Shik Lee, Soyoung Kim, Kyung-Soo Nam
      International Journal of Oncology.2017; 50(2): 727.     CrossRef
    • Influence of Socioeconomic Status, Comorbidity, and Disability on Late-stage Cancer Diagnosis
      Bo Ram Park, So Young Kim, Dong Wook Shin, Hyung Kook Yang, Jong Hyock Park
      Osong Public Health and Research Perspectives.2017; 8(4): 264.     CrossRef
    • Research Progress of Differentiated Thyroid Carcinoma
      景菊 莫
      Medical Diagnosis.2017; 07(03): 60.     CrossRef
    • High C-reactive protein level is associated with high-risk adenoma
      Hyae Min Lee, Jae Myung Cha, Jung Lok Lee, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Jin Young Yoon, Joung Il Lee
      Intestinal Research.2017; 15(4): 511.     CrossRef
    • Associations between Health Literacy, Cancer-Related Knowledge, and Preventive Health Behaviors in Community-Dwelling Korean Adults
      Youn-Jung Son, Sun-Hee Kim, Gi Yon Kim, Heesook Son
      Journal of Health Communication.2017; 22(12): 999.     CrossRef
    • Percentage Decline of Parathyroid Hormone Level is a Predictor for Post-thyroidectomy Symptomatic Hypocalcemia
      Dami Jung, Jong-kyu Kim, Hyungju Kwon, Woosung Lim, Byung-In Moon
      Journal of Endocrine Surgery.2017; 17(4): 168.     CrossRef
    • Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma
      Hyungjoo Kim, Tae Sung Ahn, Chang-Jin Kim, Sang Byung Bae, Han Jo Kim, Chang-Seuk Lee, Tae Hyun Kim, Jungkyun Im, Sang Hun Lee, Myoung Won Son, Moon Soo Lee, Moo Jun Baek, Dongjun Jeong
      Oncology Letters.2017; 14(1): 553.     CrossRef
    • Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells
      Myung-Ha Song, Ye-Rin Kim, Jae-Ho Bae, Chang-Hun Lee, Sang-Yull Lee
      Oncology Letters.2017; 13(2): 784.     CrossRef
    • A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival
      Young-Woo Kim, Mi-Jung Kim, Keun Won Ryu, Hyeong-Seok Lim, Jun Ho Lee, Sun-Young Kong, Jong Seok Lee, Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Soo-Jeong Cho, Myeong-Cherl Kook, Young-Iee Park, Seok-Ki Kim, Sook Ryun Park
      Gastric Cancer.2016; 19(2): 586.     CrossRef
    • Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer
      Heejin Kim, Kyung Jin Na, Jae Hyuk Choi, Byeong-Cheol Ahn, Dongbin Ahn, Jin Ho Sohn
      European Archives of Oto-Rhino-Laryngology.2016; 273(6): 1569.     CrossRef
    • DNA methylation analysis for the diagnosis of thyroid nodules – a pilot study with reference to BRAFV600E mutation and cytopathology results
      H. Chang, B. K. Shin, A. Kim, H. K. Kim, B. H. Kim
      Cytopathology.2016; 27(2): 122.     CrossRef
    • Current Status and Challenges of Cancer Clinical Trials in Korea
      Byoung Yong Shim, Se Hoon Park, Soonil Lee, Jin-Soo Kim, Kyoung Eun Lee, Yoon-Koo Kang, Myung-Ju Ahn
      Cancer Research and Treatment.2016; 48(1): 20.     CrossRef
    • Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer
      Qingzhong Yuan, Qingao Bu, Guoqiang Li, Jun Zhang, Tao Cui, Rui Zhu, Dongpo Mu
      Clinical Endocrinology.2016; 84(4): 564.     CrossRef
    • Public Perceptions on Cancer Incidence and Survival: A Nation-wide Survey in Korea
      Soyeun Kim, Dong Wook Shin, Hyung Kook Yang, So Young Kim, Young-Jin Ko, BeLong Cho, Young Sung Lee, Dukhyoung Lee, Keeho Park, Jong Hyock Park
      Cancer Research and Treatment.2016; 48(2): 775.     CrossRef
    • Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
      Jung Ho Im, Jinsil Seong, Ik Jae Lee, Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee, Kyung Ran Park
      Cancer Research and Treatment.2016; 48(2): 583.     CrossRef
    • Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody
      Su Jung Choi, Kyung Pyo Jung, Sun Seong Lee, Yun Soo Park, Seok Mo Lee, Sang Kyun Bae
      Nuclear Medicine and Molecular Imaging.2016; 50(2): 130.     CrossRef
    • Factors predicting outcomes of penile rehabilitation with udenafil 50 mg following radical prostatectomy
      T-H Kim, Y-S Ha, S H Choi, E S Yoo, B W Kim, S-J Yun, W-J Kim, Y S Kwon, T G Kwon
      International Journal of Impotence Research.2016; 28(1): 25.     CrossRef
    • Risk Prediction Models for Lung Cancer: A Systematic Review
      Eoin P. Gray, M. Dawn Teare, John Stevens, Rachel Archer
      Clinical Lung Cancer.2016; 17(2): 95.     CrossRef
    • Association between glutathione S-transferases M1, T1 and P1 gene polymorphisms and prostate cancer in Koreans
      Ye-Eun Shin, In-Wook Hwang, Han-Jun Jin
      Genes & Genomics.2016; 38(2): 235.     CrossRef
    • A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea
      Hee Yeon Kim, Chang Wook Kim, Jong Young Choi, Chung-Hwa Park, Chang Don Lee, Hyeon Woo Yim
      Chinese Medical Journal.2016; 129(1): 15.     CrossRef
    • Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
      Boyoung Park, Sohee Park, Hai-Rim Shin, Aesun Shin, Yohwan Yeo, Ji-Yeob Choi, Kyu-Won Jung, Byoung-Gie Kim, Yong-Man Kim, Dong-Young Noh, Sei-Hyun Ahn, Jae Weon Kim, Sokbom Kang, Jae Hoon Kim, Tae Jin Kim, Daehee Kang, Keun-Young Yoo, Sue K. Park
      BMC Cancer.2016;[Epub]     CrossRef
    • Computer-aided diagnosis for classifying benign versus malignant thyroid nodules based on ultrasound images: A comparison with radiologist-based assessments
      Yongjun Chang, Anjan Kumar Paul, Namkug Kim, Jung Hwan Baek, Young Jun Choi, Eun Ju Ha, Kang Dae Lee, Hyoung Shin Lee, DaeSeock Shin, Nakyoung Kim
      Medical Physics.2016; 43(1): 554.     CrossRef
    • Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
      Young Saing Kim, Eun Kyung Cho, Hyun Sun Woo, Junshik Hong, Hee Kyung Ahn, Inkeun Park, Sun Jin Sym, Sun Young Kyung, Shin Myung Kang, Jeong-Woong Park, Sung Hwan Jeong, Jinny Park, Jae Hoon Lee, Dong Bok Shin
      Cancer Research and Treatment.2016; 48(1): 80.     CrossRef
    • A feasibility study for anatomical noise reduction in dual-energy chest digital tomosynthesis
      D. Lee, Y.-s. Kim, S. Choi, H. Lee, S. Choi, H.-J. Kim
      Journal of Instrumentation.2016; 11(01): P01016.     CrossRef
    • HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
      Hae Ryung Chang, Seungyoon Nam, Myeong-Cherl Kook, Kyung-Tae Kim, Xiuping Liu, Hui Yao, Hae Rim Jung, Robert Lemos, Hye Hyun Seo, Hee Seo Park, Youme Gim, Dongwan Hong, Iksoo Huh, Young-Woo Kim, Dongfeng Tan, Chang-Gong Liu, Garth Powis, Taesung Park, Han
      Gut.2016; 65(1): 19.     CrossRef
    • Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer
      Arne Kutzner, Klaus Heese
      Cancer Investigation.2016; 34(2): 64.     CrossRef
    • Long-term outcomes of palliation for unresectable colorectal cancer obstruction in patients with good performance status: endoscopic stent versus surgery
      Hyo Jun Ahn, Sang Woo Kim, Sung Won Lee, Soon Wook Lee, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, In Seok Lee, Myung-Gyu Choi
      Surgical Endoscopy.2016; 30(11): 4765.     CrossRef
    • MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1
      Fei Zeng, Min Xue, Ting Xiao, Yueran Li, Songshu Xiao, Bin Jiang, Caiping Ren
      Biomedicine & Pharmacotherapy.2016; 79: 294.     CrossRef
    • Is the 5-ports approach necessary in laparoscopic gastrectomy? Feasibility of reduced-port totally laparoscopic gastrectomy for the treatment of gastric cancer: A Prospective Cohort Study
      Ho Seok Seo, Han Hong Lee
      International Journal of Surgery.2016; 29: 118.     CrossRef
    • The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase 18F-FDG PET/CT
      Hansol Moon, Woo Chul Noh, Hyun-Ah Kim, Eun-Kyu Kim, Ko Woon Park, Seung Sook Lee, Joon Ho Choi, Kyung Woo Han, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Sang Moo Lim
      Nuclear Medicine and Molecular Imaging.2016; 50(3): 246.     CrossRef
    • Negative Public Attitudes towards Cancer Survivors Returning to Work: A Nationwide Survey in Korea
      Hye-Young Shim, Ji-Yeon Shin, Jong Heun Kim, So-Young Kim, Hyung-Kook Yang, Jong-Hyock Park
      Cancer Research and Treatment.2016; 48(2): 815.     CrossRef
    • Re
      Sadao Suzuki
      Epidemiology.2016; 27(3): e19.     CrossRef
    • Chronic lymphocytic leukemia: a clinical review including Korean cohorts
      Young-Woo Jeon, Seok-Goo Cho
      The Korean Journal of Internal Medicine.2016; 31(3): 433.     CrossRef
    • Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma
      Sayamaa Lkhagvadorj, Ji-Hee Kim, Sung-Soo Oh, Mi-Ra Lee, Jae Hung Jung, Hyun Chul Chung, Seung-Kuy Cha, Minseob Eom
      Journal of Korean Medical Science.2016; 31(6): 879.     CrossRef
    • Ultrasound-Guided Laser Ablation Using Multidirectional-Firing Fiber for Papillary Thyroid Carcinoma: An Ex Vivo Study with Evaluation of Tumor Cell Viability
      Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Seung Ook Hwang, Ji Young Park, Ji Yun Jeong, Changhwan Kim, Ik-Bu Sohn, Ho Lee, Ho Yong Park
      Photomedicine and Laser Surgery.2016; 34(7): 300.     CrossRef
    • Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer
      Hyung-Jun Im, Suthet Oo, Woohyun Jung, Jin-Young Jang, Sun-Whe Kim, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, E. Edmund Kim, Dong Soo Lee
      Medicine.2016; 95(19): e3686.     CrossRef
    • Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women
      Min-Jeong Kim, Jin-Ju Kim, Sun Mie Kim
      Obstetrics & Gynecology Science.2016; 59(3): 192.     CrossRef
    • Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer–A multicenter randomized phase III clinical trial (SENORITA trial) protocol
      Ji Yeon Park, Young-Woo Kim, Keun Won Ryu, Byung-Ho Nam, Young Joon Lee, Sang Ho Jeong, Ji-Ho Park, Hoon Hur, Sang-Uk Han, Jae Seok Min, Ji Yeong An, Woo Jin Hyung, Gyu Seok Cho, Gui Ae Jeong, Oh Jeong, Young Kyu Park, Mi Ran Jung, Hong Man Yoon, Bang Woo
      BMC Cancer.2016;[Epub]     CrossRef
    • Clinical value of pathologic examination of non-neoplastic kidney in patients with upper urinary tract malignancies
      Jee Wan Wee, Hye Ran Kang, Soon Hyo Kwon, Jin Seok Jeon, Dong Cheol Han, So-Young Jin, Won Jae Yang, Hyunjin Noh
      The Korean Journal of Internal Medicine.2016; 31(4): 739.     CrossRef
    • The clinical utilization of radiation therapy in Korea between 2009 and 2013
      Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Young Seok Seo, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Hyun Jin Song
      Radiation Oncology Journal.2016; 34(2): 88.     CrossRef
    • Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
      Michael Carlberg, Lena Hedendahl, Mikko Ahonen, Tarmo Koppel, Lennart Hardell
      BMC Cancer.2016;[Epub]     CrossRef
    • Influence of body habitus on the surgical outcomes of bilateral axillo-breast approach robotic thyroidectomy in papillary thyroid carcinoma patients
      Hee Seung Lee, Young Jun Chai, Su-Jin Kim, June Young Choi, Kyu Eun Lee
      Annals of Surgical Treatment and Research.2016; 91(1): 1.     CrossRef
    • Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer
      Jing Hui Jin, Hyun-Jung Kim, Chan Young Kim, Yun Hwan Kim, Woong Ju, Seung Cheol Kim
      Obstetrics & Gynecology Science.2016; 59(4): 279.     CrossRef
    • In which group of gastric cancer patients is the preoperative neutrophil-to-lymphocyte ratio a significant prognostic factor?
      Hee-Soon Chang, Dong-Seok Han, Ho Yoon Bang, Pyeong Su Kim, Kyung-Yung Lee
      Korean Journal of Clinical Oncology.2016; 12(1): 19.     CrossRef
    • Gastric biomarker study using proteomic method
      Sang-Ho Jeong, Young-Joon Lee, Soon-Chan Hong, Woo-Song Ha
      Korean Journal of Clinical Oncology.2016; 12(1): 7.     CrossRef
    • Oncologic outcomes of squamous cell carcinoma of the anal canal after chemoradiation therapy
      Dae Ro Lim, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim
      Korean Journal of Clinical Oncology.2016; 12(1): 41.     CrossRef
    • Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer
      Yong Hyun Park, Hyun Woo Shin, Ae Ryang Jung, Oh Sung Kwon, Yeong-Jin Choi, Jaesung Park, Ji Youl Lee
      Scientific Reports.2016;[Epub]     CrossRef
    • Clinical characteristics and potential aetiologies of non‐B non‐C hepatocellular carcinoma in hepatitis B virus endemic area
      Seung Bum Lee, Kang Mo Kim, Jihyun An, Danbi Lee, Ju Hyun Shim, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Yung Sang Lee
      Liver International.2016; 36(9): 1351.     CrossRef
    • Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method
      Bibihajar Zahmatkesh, Afsaneh Keramat, Nasrinossadat Alavi, Ahmad Khosravi, Ahmad Kousha, Ali Ghanbari Motlagh, Mahboobeh Darman, Elham Partovipour, Reza Chaman
      Asian Pacific Journal of Cancer Prevention.2016; 17(3): 1493.     CrossRef
    • Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
      Hong Seok Lee, Doo Ho Choi, Hee Chul Park, Won Park, Jeong Il Yu, Kwangzoo Chung
      Radiation Oncology Journal.2016; 34(3): 186.     CrossRef
    • Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial
      Sang Myung Woo, Jungnam Joo, So Young Kim, Sang-Jae Park, Sung-Sik Han, Tae Hyun Kim, Young Hwan Koh, Seung Hyun Chung, Yun-Hee Kim, Hae Moon, Eun Kyung Hong, Woo Jin Lee
      Pancreatology.2016; 16(6): 1099.     CrossRef
    • Surgical and obstetrical outcomes after laparoscopic radical trachelectomy and pelvic lymphadenectomy for early cervical cancer
      So-Eun Yoo, Kyeong A So, Seon-Ah Kim, Mi Kyung Kim, Yoo Kyung Lee, In-Ho Lee, Tae-Jin Kim, Ki Heon Lee
      Obstetrics & Gynecology Science.2016; 59(5): 373.     CrossRef
    • Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
      Kijong Yi, Hyunsung Kim, Yumin Chung, Hyein Ahn, Jongmin Sim, Young Chan Wi, Ju Yeon Pyo, Young-Soo Song, Seung Sam Paik, Young-Ha Oh
      Journal of Pathology and Translational Medicine.2016; 50(5): 327.     CrossRef
    • Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center
      Hyung Chul Park, Do Hoon Kim, Eun Jeong Gong, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung, Jin-Ho Kim
      The Korean Journal of Internal Medicine.2016; 31(6): 1064.     CrossRef
    • Cytogenetic status and oxidative stress parameters in patients with thyroid diseases
      Marko Gerić, Ana Marija Domijan, Valentina Gluščić, Renato Janušić, Božena Šarčević, Vera Garaj-Vrhovac
      Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2016; 810: 22.     CrossRef
    • Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability
      Ji-Ye Kee, Yo-Han Han, Dae-Seung Kim, Jeong-Geon Mun, Jinbong Park, Mi-Young Jeong, Jae-Young Um, Seung-Heon Hong
      Phytomedicine.2016; 23(13): 1680.     CrossRef
    • Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up
      Yoo Mi Park, Jie-Hyun Kim, Su Jung Baik, Jae Jun Park, Young Hoon Youn, Hyojin Park
      Medicine.2016; 95(44): e5351.     CrossRef
    • Anti-proliferative Effects of Acid Extract of Gracilaria Verrucosa on Primary Human Prostate Cancer Cells
      Seong-Min Hong, Hyun-Dong Cho, Jeong-Ho Kim, Ju-Hye Lee, Woo-Si Song, Sung-Tae Lee, Mi-Kyung Lee, Kwon-Il Seo
      Journal of Life Science.2016; 26(10): 1130.     CrossRef
    • The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)
      Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Hae Su Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park, Shian-Ying Sung
      PLOS ONE.2016; 11(2): e0149432.     CrossRef
    • Target Therapy in Unresectable or Metastatic Colorectal Cancer
      Jae Hyun Kim, Seun Ja Park
      The Korean Journal of Gastroenterology.2016; 68(6): 303.     CrossRef
    • RhoA is associated with invasion and poor prognosis in colorectal cancer
      DONGJUN JEONG, SOYOUNG PARK, HYUNGJOO KIM, CHANG-JIN KIM, TAE SUNG AHN, SANG BYUNG BAE, HAN JO KIM, TAE HYUN KIM, JUNGKYUN IM, MOON SOO LEE, HYOG YOUNG KWON, MOO JUN BAEK
      International Journal of Oncology.2016; 48(2): 714.     CrossRef
    • Is forceps more useful than visualization for measurement of colon polyp size?
      Jae Hyun Kim, Seun Ja Park, Jong Hoon Lee, Tae Oh Kim, Hyun Jin Kim, Hyung Wook Kim, Sang Heon Lee, Dong Hoon Baek
      World Journal of Gastroenterology.2016; 22(11): 3220.     CrossRef
    • Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation
      Hye-Young Min, Hye-Jin Boo, Ho Jin Lee, Hyun-Ji Jang, Hye Jeong Yun, Su Jung Hwang, John Kendal Smith, Hyo-Jong Lee, Ho-Young Lee
      Oncotarget.2016; 7(43): 70936.     CrossRef
    • Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer
      Ita Novita Sari, Ying-Gui Yang, Lan Thi Hanh Phi, Hyungjoo Kim, Moo Jun Baek, Dongjun Jeong, Hyog Young Kwon
      Oncotarget.2016; 7(52): 86039.     CrossRef
    • Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
      Byoung Jo Suh
      Case Reports in Oncology.2016; 9(3): 752.     CrossRef
    • Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea
      Hye Sook Kim, Suk Young Lee, Ju Won Kim, Yoon Ji Choi, In Hae Park, Keun Seok Lee, Jae Hong Seo, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Kyong Hwa Park
      Oncology.2016; 91(5): 274.     CrossRef
    • Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution
      Dong Hoe Koo, Min-Hee Ryu, Baek-Yeol Ryoo, Jinjoo Seo, Mi-Yeon Lee, Heung-Moon Chang, Jae-Lyun Lee, Sung-Sook Lee, Tae Won Kim, Yoon-Koo Kang
      Gastric Cancer.2015; 18(2): 346.     CrossRef
    • Robotic modified radical neck dissection by bilateral axillary breast approach for papillary thyroid carcinoma with lateral neck metastasis
      Byung Seup Kim, Kyung Ho Kang, Sung Jun Park
      Head & Neck.2015; 37(1): 37.     CrossRef
    • Age and sex interactions in gastric cancer incidence and mortality trends in Korea
      Minkyo Song, Daehee Kang, Jae Jeong Yang, Ji-Yeob Choi, Hyuna Sung, Yunhee Lee, Hyung-Suk Yoon, Yunhee Choi, Seong-Ho Kong, Hyuk-Joon Lee, Han-Kwang Yang, Woo Ho Kim
      Gastric Cancer.2015; 18(3): 580.     CrossRef
    • Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa
      Yoon Jin Choi, Nayoung Kim, Aesun Shin, Hye Seung Lee, Ryoung Hee Nam, Hyun Chang, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Ji Hyun Park, Hyun Chae Jung
      Gastric Cancer.2015; 18(3): 526.     CrossRef
    • Preoperative smoking cessation can reduce postoperative complications in gastric cancer surgery
      Kuk Hyun Jung, Su Mi Kim, Min Gew Choi, Jun Ho Lee, Jae Hyung Noh, Tae Sung Sohn, Jae Moon Bae, Sung Kim
      Gastric Cancer.2015; 18(4): 683.     CrossRef
    • Elevated risks of subsequent primary malignancies in patients with thyroid cancer: A nationwide, population‐based study in Korea
      Yoon Young Cho, Jiwon Lim, Chang‐Mo Oh, Junsun Ryu, Kyu‐Won Jung, Jae Hoon Chung, Young‐Joo Won, Sun Wook Kim
      Cancer.2015; 121(2): 259.     CrossRef
    • Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17)
      Subrata Pramanik, Arne Kutzner, Klaus Heese
      Tumor Biology.2015; 36(1): 239.     CrossRef
    • Radical prostatectomy versus external beam radiotherapy for localized prostate cancer
      Yeon-Joo Kim, Kwan Ho Cho, Hong Ryull Pyo, Kang Hyun Lee, Sung Ho Moon, Tae Hyun Kim, Kyung Hwan Shin, Joo-Young Kim, Young-kyung Kim, Se Byeong Lee
      Strahlentherapie und Onkologie.2015; 191(4): 321.     CrossRef
    • Risk of Lymph Node Metastasis in Differentiated Type Mucosal Early Gastric Cancer Mixed with Minor Undifferentiated Type Histology
      Jun Ho Lee, Il Ju Choi, Hye Seung Han, Young-Woo Kim, Keun Won Ryu, Hong Man Yoon, Bang Wool Eom, Chan Gyoo Kim, Jong Yeul Lee, Soo-Jeong Cho, Young-Il Kim, Byung-Ho Nam, Myeong-Cherl Kook
      Annals of Surgical Oncology.2015; 22(6): 1813.     CrossRef
    • Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer
      Sung Hoon Sim, Yu Jung Kim, Se Hyun Kim, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
      Journal of Cancer Research and Clinical Oncology.2015; 141(6): 1073.     CrossRef
    • The radiologic technologists’ health study in South Korea: study design and baseline results
      Won Jin Lee, Mina Ha, Seung-sik Hwang, Kyoung-Mu Lee, Young-Woo Jin, Meeseon Jeong, Jae Kwan Jun, Eun Shil Cha, Yousun Ko, Kyung-Hwa Choi, Jung-Eun Lee
      International Archives of Occupational and Environmental Health.2015; 88(6): 759.     CrossRef
    • Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies
      Soriul Kim, Chol Shin, Sun Ha Jee
      Gene.2015; 556(2): 199.     CrossRef
    • Decreased Expression of Heat Shock Protein 20 in Colorectal Cancer and Its Implication in Tumorigenesis
      Young-Tae Ju, Seung-Jin Kwag, Hee Jin Park, Eun-Jung Jung, Chi-Young Jeong, Sang-Ho Jeong, Young-Joon Lee, Sang-Kyung Choi, Kee Ryeon Kang, Young-Sool Hah, Soon-Chan Hong
      Journal of Cellular Biochemistry.2015; 116(2): 277.     CrossRef
    • Laparoscopic resectional gastric bypass: initial experience in morbidly obese Korean patients
      Ji Yeon Park, Yong Jin Kim
      Surgery Today.2015; 45(8): 1032.     CrossRef
    • Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced‐intensity and myeloablative conditioning
      Koung Jin Suh, Inho Kim, Jin Lim, Hyerim Ha, Seongyeol Park, Youngil Koh, Sung‐Soo Yoon, Seonyang Park
      Clinical Transplantation.2015; 29(2): 124.     CrossRef
    • Diagnosis and management of prostate cancer
      Won Park
      Journal of the Korean Medical Association.2015; 58(1): 5.     CrossRef
    • Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy
      Juhan Lee, Yoo-Min Kim, Yanghee Woo, Kazutaka Obama, Sung Hoon Noh, Woo Jin Hyung
      Surgical Endoscopy.2015; 29(11): 3251.     CrossRef
    • Clinical Characteristics of Early-Stage Gallbladder Cancer
      Bonggyu Seong, Ju Yeun Song, Sun Youn Bae, Kwang Hyuck Lee, Jong Kyun Lee, Jong Chul Rhee, Kyu Taek Lee
      Korean Journal of Medicine.2015; 88(2): 161.     CrossRef
    • Effects of oriental medicine music therapy in an ovarian cancer patient with So-Eum-type constitution: a case report
      Seung-Hyun Lee, Eunhye Song, Seul-Ki Kim
      Integrative Medicine Research.2015; 4(1): 48.     CrossRef
    • Clinical features of lung adenocarcinomas with epidermal growth factor receptor mutations and miliary disseminated carcinomatosis
      Hee Joung Kim, Seong Hui Kang, Hyun Woo Chung, Jong Sik Lee, Sun Jong Kim, Kwang Ha Yoo, Kye Young Lee
      Thoracic Cancer.2015; 6(5): 629.     CrossRef
    • Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey
      Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Su Hyun Lee, Beomseok Suh, Hee-Young Shin, Hyun Joo Lee, Dae Ghon Kim, Jong Hyock Park
      Cancer Research and Treatment.2015; 47(4): 591.     CrossRef
    • Protocol of a Thyroid Cancer Longitudinal Study (T-CALOS): a prospective, clinical and epidemiological study in Korea
      Kyu Eun Lee, Young Joo Park, Belong Cho, Yunji Hwang, June Young Choi, Su-jin Kim, Hoonsung Choi, Ho-Chun Choi, Ah Reum An, Do Joon Park, Sue K Park, Yeo-Kyu Youn
      BMJ Open.2015; 5(1): e007234.     CrossRef
    • Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors
      Maria Lee, Yun Hwan Kim, Myung Jae Jeon
      Psycho-Oncology.2015; 24(9): 1097.     CrossRef
    • Multiple primary cancers involving lung cancer at a single tertiary hospital: Clinical features and prognosis
      Seo Woo Kim, Kyoung Ae Kong, Do‐Youn Kim, Yon Ju Ryu, Jin Hwa Lee, Jung Hyun Chang
      Thoracic Cancer.2015; 6(2): 159.     CrossRef
    • Prevalence and outcomes of extrahepatic primary malignancy associated with Hepatocellular Carcinoma in a Korean population
      Sukho Hong, Sook-Hyang Jeong, Sang Soo Lee, Jung Wha Chung, Sung Wook Yang, Seong Min Chung, Eun Sun Jang, Jin-Wook Kim, Jee Hyun Kim, Haeryoung Kim, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han
      BMC Cancer.2015;[Epub]     CrossRef
    • Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution
      Alfred Wei Chieh Kow, Choon Hyuck David Kwon, Sanghyun Song, Jong Man Kim, Jae-Won Joh
      Surgery.2015; 157(4): 645.     CrossRef
    • Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
      Hyein Ahn, Jongmin Sim, Rehman Abdul, Min Sung Chung, Seung Sam Paik, Young-Ha Oh, Chan Kum Park, Kiseok Jang
      Journal of Korean Medical Science.2015; 30(4): 390.     CrossRef
    • A Closer Look at Papillary Thyroid Carcinoma
      Won Bae Kim
      Endocrinology and Metabolism.2015; 30(1): 1.     CrossRef
    • Local Control of Brain Metastasis: Treatment Outcome of Focal Brain Treatments in Relation to Subtypes
      Jae Uk Chong, Sung Gwe Ahn, Hak Min Lee, Jong Tae Park, Seung Ah Lee, Seho Park, Joon Jeong, Seung Il Kim
      Journal of Breast Cancer.2015; 18(1): 29.     CrossRef
    • The benefits of preincision ropivacaine infiltration for reducing postoperative pain after robotic bilateral axillo-breast approach thyroidectomy: a prospective, randomized, double-blind, placebo-controlled study
      Kyung Ho Kang, Byung Seup Kim, Hyun Kang
      Annals of Surgical Treatment and Research.2015; 88(4): 193.     CrossRef
    • Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients
      In-Chang Cho, Jeong Eun Kim, Sung Han Kim, Jae Young Joung, Ho Kyung Seo, Jinsoo Chung, Weon Seo Park, Kang Hyun Lee
      Prostate International.2015; 3(2): 56.     CrossRef
    • Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected
      H. Sung, P. S. Rosenberg, W.-Q. Chen, M. Hartman, W.-y. Lim, K. S. Chia, O. Wai-Kong Mang, C.-J. Chiang, D. Kang, R. K.-C. Ngan, L. A. Tse, W. F. Anderson, X. R. Yang
      JNCI Journal of the National Cancer Institute.2015; 107(7): djv107.     CrossRef
    • The Effects of Laughter Therapy on Mood State and Self-Esteem in Cancer Patients Undergoing Radiation Therapy: A Randomized Controlled Trial
      So Hee Kim, Jeong Ran Kook, Moonjung Kwon, Myeong Ha Son, Seung Do Ahn, Yeon Hee Kim
      The Journal of Alternative and Complementary Medicine.2015; 21(4): 217.     CrossRef
    • Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells
      Yoon Jin Choi, Nayoung Kim, Hyun Chang, Hye Seung Lee, Seon Mee Park, Ji Hyun Park, Cheol Min Shin, Jung Mogg Kim, Joo Sung Kim, Dong Ho Lee, Hyun Chae Jung
      Carcinogenesis.2015; 36(5): 553.     CrossRef
    • Gastric Cancer in Asian American Populations: a Neglected Health Disparity
      Victoria M. Taylor, Linda K. Ko, Joo Ha Hwang, Mo-Kyung Sin, John M. Inadomi
      Asian Pacific Journal of Cancer Prevention.2015; 15(24): 10565.     CrossRef
    • Cancer mortality in Brazil
      Isabelle R. Barbosa, Dyego L.B. de Souza, María M. Bernal, Íris do C.C. Costa
      Medicine.2015; 94(16): e746.     CrossRef
    • Need to Pay More Attention to Attendance at Follow-Up Consultation after Cancer Screening in Smokers and Drinkers
      Jaeyong Shin, Eun-Cheol Park, Hong-Chul Bae, Seri Hong, Suk-Yong Jang, Jae-Hyun Kim, Jee Suk Chang, Sang Gyu Lee
      Asian Pacific Journal of Cancer Prevention.2015; 16(1): 109.     CrossRef
    • Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study
      Yejin Mok, Heejin Kimm, Sang Yop Shin, Sun Ha Jee, Elizabeth A. Platz
      Urology.2015; 85(5): 1111.     CrossRef
    • Determinants of gastric cancer screening attendance in Korea: a multi-level analysis
      Yunryong Chang, Belong Cho, Ki Young Son, Dong Wook Shin, Hosung Shin, Hyung-Kook Yang, Aesun Shin, Keun-Young Yoo
      BMC Cancer.2015;[Epub]     CrossRef
    • A case-control study of genotoxicity endpoints in patients with papillary thyroid cancer
      Marko Gerić, Renato Janušić, Božena Šarčević, Vera Garaj-Vrhovac
      Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2015; 784-785: 47.     CrossRef
    • Short Low Concentration Cisplatin Treatment Leads to an Epithelial Mesenchymal Transition-like Response in DU145 Prostate Cancer Cells
      Yi-Qing Liu, Guo-An Zhang, Bing-Chang Zhang, Yong Wang, Zheng Liu, Yu-Lian Jiao, Ning Liu, Yue-Ran Zhao
      Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1025.     CrossRef
    • Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case–control study
      Seho Park, Dong Hoon Lee, Justin Y. Jeon, Jegyu Ryu, Sanghwa Kim, Jee Ye Kim, Hyung Seok Park, Seung Il Kim, Byeong-Woo Park
      Breast Cancer Research and Treatment.2015; 152(1): 147.     CrossRef
    • Incidence of kidney, bladder, and prostate cancers in Korea: An update
      Wan Song, Hwang Gyun Jeon
      Korean Journal of Urology.2015; 56(6): 422.     CrossRef
    • Overexpressions of Vimentin and Integrins in Human Metastatic Spine Tumors
      Sung Bae Park, Young-Joon Ryu, Young Seob Chung, Chi Heon Kim, Chun Kee Chung
      Journal of Korean Neurosurgical Society.2015; 57(5): 329.     CrossRef
    • Preventive Effect of Human Acellular Dermal Matrix on Post-thyroidectomy Scars and Adhesions
      Do Young Kim, Sang-Wook Kang, Dae Suk Kim, Jung U. Shin, Woong Youn Chung, Cheong Soo Park, Ju Hee Lee, Kee-Hyun Nam
      Dermatologic Surgery.2015; 41(7): 812.     CrossRef
    • Thyroid Cancer and Radiation
      Chong Soon Kim
      Journal of Korean Thyroid Association.2015; 8(1): 1.     CrossRef
    • New Strategies for Combined Radioiodine Therapy in Refractory Thyroid Cancer
      So Won Oh, Jin Chul Paeng, June-Key Chung
      Journal of Korean Thyroid Association.2015; 8(1): 26.     CrossRef
    • The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database
      Zisun Kim, Sun Young Min, Chan Seok Yoon, Kyu-Won Jung, Beom Seok Ko, Eunyoung Kang, Seok Jin Nam, Seokwon Lee, Min Hee Hur
      Journal of Breast Cancer.2015; 18(2): 103.     CrossRef
    • Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea
      Gi Hyeon Seo, Yoon Young Cho, Jae Hoon Chung, Sun Wook Kim
      Thyroid.2015; 25(8): 927.     CrossRef
    • Evaluating hypertrophic thyroidectomy scar outcomes after treatment with triamcinolone injections and copper bromide laser therapy
      Hye Rang On, Sang Hee Lee, Yong Sang Lee, Hang‐Seok Chang, CheongSoo Park, Mi Ryung Roh
      Lasers in Surgery and Medicine.2015; 47(6): 479.     CrossRef
    • Clinicopathological characteristics and prognosis in old age breast cancer
      Beom Seok Lee, Shinhee Hong, Kwan Il Kim, Tae Ryung Kim, Kyung Hee Lee, Tae Hoon Lee, Heung Kyu Park, Yong Soon Chun
      Korean Journal of Clinical Oncology.2015; 11(1): 6.     CrossRef
    • All-or-(N)One – an epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci
      Arne Kutzner, Subrata Pramanik, Pok-Son Kim, Klaus Heese
      Genomics.2015; 106(5): 278.     CrossRef
    • Sex-age-specific association of body mass index with all-cause mortality among 12.8 million Korean adults: a prospective cohort study
      Sang-Wook Yi, Heechoul Ohrr, Soon-Ae Shin, Jee-Jeon Yi
      International Journal of Epidemiology.2015; 44(5): 1696.     CrossRef
    • Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
      Janghee Lee, Seho Park, Sanghwa Kim, Jeeye Kim, Jegyu Ryu, Hyung Seok Park, Seung Il Kim, Byeong-Woo Park
      Yonsei Medical Journal.2015; 56(5): 1213.     CrossRef
    • Health Behaviors of Cancer Survivors in Nationwide Cross-Sectional Survey in Korea
      Boyoung Park, Sun-Young Kong, Jeongseon Kim, Yeol Kim, In Hae Park, So-Youn Jung, Eun Sook Lee
      Medicine.2015; 94(31): e1214.     CrossRef
    • Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist’s view of the ARTIST randomized phase III trial
      Jeong Il Yu, Do Hoon Lim, Yong Chan Ahn, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Seung Tae Kim, Sung Kim, Tae Sung Sohn, Min Gew Choi, Jae Moon Bae, Heerim Nam
      Radiotherapy and Oncology.2015; 117(1): 171.     CrossRef
    • Functional Improvement After 4-Week Rehabilitation Therapy and Effects of Attention Deficit in Brain Tumor Patients: Comparison With Subacute Stroke Patients
      Eun Young Han, Min Ho Chun, Bo Ryun Kim, Ha Jeong Kim
      Annals of Rehabilitation Medicine.2015; 39(4): 560.     CrossRef
    • The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test
      Yong Cheol Kim, Jeong Ho Kim, Dae Young Cheung, Tae Ho Kim, Eun Jung Jun, Jung-Whan Oh, Chang Whan Kim, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim, Jin Il Kim, Soo-Heon Park, Jae Kwang Kim
      Gut and Liver.2015;[Epub]     CrossRef
    • Socioeconomic Disparities in Colorectal Cancer Screening in Korea
      Mina Suh, Kui Son Choi, Hoo-Yeon Lee, Myung-Il Hahm, Yoon Young Lee, Jae Kwan Jun, Eun-Cheol Park
      Medicine.2015; 94(39): e1368.     CrossRef
    • Comparison of short-term outcomes and acute inflammatory response between laparoscopy-assisted and totally laparoscopic distal gastrectomy for early gastric cancer
      Sang-Ho Lee, In-Ho Kim, In-Hwan Kim, Sang-Gyu Kwak, Hyun-Dong Chae
      Annals of Surgical Treatment and Research.2015; 89(4): 176.     CrossRef
    • Anticancer activity of CopA3 dimer peptide in human gastric cancer cells
      Joon Ha Lee, In-Woo Kim, Sang-Hee Kim, Eun-Young Yun, Sung-Hee Nam, Mi-Young Ahn, Dong-Chul Kang, Jae Sam Hwang
      BMB Reports.2015; 48(6): 324.     CrossRef
    • Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
      Su Jin Lee, Sungmin Kim, Moonjin Kim, Jeeyun Lee, Yeon Hee Park, Young-Hyuck Im, Se Hoon Park
      BMC Cancer.2015;[Epub]     CrossRef
    • Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea
      Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun
      Medicine.2015; 94(41): e1469.     CrossRef
    • Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009
      Sang-Hoon Shin, Kyu-Won Jung, Johyun Ha, Seung Hoon Lee, Young-Joo Won, Heon Yoo
      Cancer Research and Treatment.2015; 47(4): 569.     CrossRef
    • Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study
      Young Saing Kim, Sun Jin Sym, Min Young Baek, Inkeun Park, Junshik Hong, Hee Kyung Ahn, Jinny Park, Eun Kyung Cho, Woon Ki Lee, Min Chung, Hyung-Sik Kim, Jae Hoon Lee, Dong Bok Shin
      Cancer Chemotherapy and Pharmacology.2015; 76(6): 1267.     CrossRef
    • Reliability and Validity of the Korean Version of the Modified Adult Attachment Scale for the Use of Medically Ill Patients
      Byunggu Jang, Hyo-Deog Rim, Jungmin Woo
      Psychiatry Investigation.2015; 12(4): 483.     CrossRef
    • Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection for Organ Preserving Surgery in Gastric Cancer
      Young Joon Lee, Sang Ho Jeong, Hoon Hur, Sang-Uk Han, Jae Seok Min, Ji Yeong An, Woo Jin Hyung, Gyu Seok Cho, Gui Ae Jeong, Oh Jeong, Young Kyu Park, Mi Ran Jung, Young-Woo Kim, Hong Man Yoon, Bang Wool Eom, Ji Yeon Park, Keun Won Ryu
      Medicine.2015; 94(43): e1894.     CrossRef
    • Treatment Strategy after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma: A Single Institution Experience
      Hyun Jik Lee, Hyuk Lee, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee
      Gut and Liver.2015; 9(6): 713.     CrossRef
    • Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer
      Li-Kui Yin, Xue-Qing Sun, Dong-Zhen Mou
      Asian Pacific Journal of Cancer Prevention.2015; 16(9): 3867.     CrossRef
    • Trends in major cancer mortality in Korea, 1983–2012, with a joinpoint analysis
      Daroh Lim, Mina Ha, Inmyung Song
      Cancer Epidemiology.2015; 39(6): 939.     CrossRef
    • Differences in Incidence, Mortality and Survival of Breast Cancer by Regions and Countries in Asia and Contributing Factors
      Yeonju Kim, Keun-Young Yoo, Marc T Goodman
      Asian Pacific Journal of Cancer Prevention.2015; 16(7): 2857.     CrossRef
    • Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy
      Tae Sun Kim, Kwang Jin Ko, Seung Jea Shin, Hyun Soo Ryoo, Wan Song, Hyun Hwan Sung, Deok Hyun Han, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Kyu Sung Lee, Sung Won Lee, Hyun Moo Lee, Han Yong Choi, Hwang Gyun Jeon
      Korean Journal of Urology.2015; 56(12): 796.     CrossRef
    • Diagnostic Thyroidectomy May Be Preferable in Patients With Suspicious Ultrasonography Features After Cytopathology Diagnosis of AUS/FLUS in the Bethesda System
      Yong Sang Lee, Hyeung Kyoo Kim, Hojin Chang, Seok Mo Kim, Bup-Woo Kim, Hang-Seok Chang, Cheong Soo Park
      Medicine.2015; 94(51): e2183.     CrossRef
    • Impact of the availability of active cytotoxic agents on the survival of patients with advanced gastric cancer
      BYUNG HA CHO, HYE SOOK HAN, JIHYUN KWON, JOUNG-HO HAN, SOON MAN YOON, DAE HOON KIM, HYO YUNG YUN, KI HYEONG LEE, SEI JIN YOUN, SEUNG TAIK KIM
      Oncology Letters.2015; 10(4): 2481.     CrossRef
    • Burden Assessment of Thyroid cancer in Iran from 1990 to 2010: Lessons Obtained from Global Burden of Disease Report 2010
      Mitra Modirian, Zahra Cheraghi, Shadi Rahimzadeh, Sahar Saeedi Moghaddam, Alireza Mosavi Jarrahi
      Asian Pacific Journal of Cancer Prevention.2015; 16(17): 7743.     CrossRef
    • Influences of Symptom Experience and Depression on Quality of Life in Colorectal Cancer Patients with Stoma Reversal
      Jung Ha Kim, Hyunjung Kim
      Journal of Korean Biological Nursing Science.2015; 17(4): 306.     CrossRef
    • A Population-Based, Nationwide Cross-Sectional Study on Influenza Vaccination Status among Cancer Survivors in Korea
      Myeung Oh, Mi Han, Na-Ra Yun, Jong Park, So Ryu, Dong-Min Kim, Seong-Woo Choi
      International Journal of Environmental Research and Public Health.2015; 12(8): 10133.     CrossRef
    • Interactions between Paraoxonase 1 Genetic Polymorphisms and Smoking and Their Effects on Oxidative Stress and Lung Cancer Risk in a Korean Population
      Sang-Yong Eom, Dong-Hyuk Yim, Chul-Ho Lee, Kang-Hyeon Choe, Jin Young An, Kye Young Lee, Yong-Dae Kim, Heon Kim, Nancy Lan Guo
      PLOS ONE.2015; 10(3): e0119100.     CrossRef
    • Does hospital need more hospice beds? Hospital charges and length of stays by lung cancer inpatients at their end of life: A retrospective cohort design of 2002–2012
      Sun Jung Kim, Kyu-Tae Han, Tae Hyun Kim, Eun-Cheol Park
      Palliative Medicine.2015; 29(9): 808.     CrossRef
    • Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04
      Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim, Chang Geol Lee, Eun Kyung Cho, Kyu Chan Lee, Ming Chen, Dong-Wan Kim, Hoon-Kyo Kim, Young Joo Min, Jin-Hyoung Kang, Jin-Hyuck Choi, Sang-We Kim, Guangying Zhu, Yi-Long Wu, Sung Rok Kim, Kyung Hee Lee, Hong Suk So
      Journal of Clinical Oncology.2015; 33(24): 2660.     CrossRef
    • Relationship between Cancer Worry and Stages of Adoption for Breast Cancer Screening among Korean Women
      Eunji Choi, Yoon Young Lee, Hyo Joong Yoon, Sangeun Lee, Mina Suh, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi, Ali Montazeri
      PLOS ONE.2015; 10(7): e0132351.     CrossRef
    • Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
      Miso Kim, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Eunsik Lee, Bhumsuk Keam, Tae Min Kim, Dae Seog Heo, Se-Hoon Lee, Kyung Chul Moon, Hiromu Suzuki
      PLOS ONE.2015; 10(7): e0133371.     CrossRef
    • Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis
      Yoon Ji Choi
      World Journal of Gastroenterology.2015; 21(29): 8868.     CrossRef
    • Second-look endoscopy with prophylactic hemostasis is still effective after endoscopic submucosal dissection for gastric neoplasm
      Ji Hye Jung
      World Journal of Gastroenterology.2015; 21(48): 13518.     CrossRef
    • Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer
      Mi Sun Kim
      World Journal of Gastroenterology.2015; 21(9): 2711.     CrossRef
    • Dilution effect of serum CA125 and CA19-9 over a cutoff value, according to obesity
      Jae Heon Kim, Bo Ra Park, Won Jae Yang
      The International Journal of Biological Markers.2015; 30(1): 122.     CrossRef
    • Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas
      Sejong Chun, Su Yeon Rhie, Chang-Seok Ki, Jee Eun Kim, Hyung-Doo Park
      Annals of Hepatology.2015; 14(6): 881.     CrossRef
    • Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer
      Jeong-Yeol Park, Joo-Hyun Nam
      The Oncologist.2015; 20(3): 270.     CrossRef
    • Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer
      Jeong Won Lee, Kwanhyeong Jo, Arthur Cho, Sung Hoon Noh, Jong Doo Lee, Mijin Yun
      Journal of Nuclear Medicine.2015; 56(10): 1494.     CrossRef
    • The effects of shRNA-mediated gene silencing of transcription factor SNAI1 on the biological phenotypes of breast cancer cell line MCF-7
      Yan Lu, Lina Yu, Minlan Yang, Xiangshu Jin, Zhijing Liu, Xiaowei Zhang, Liping Wang, Dongjing Lin, Yuanyuan Liu, Min Wang, Chengshi Quan
      Molecular and Cellular Biochemistry.2014; 388(1-2): 113.     CrossRef
    • Prognostic Factors for Metastatic Colorectal Cancer after First-line Chemotherapy with FOLFOX-4 or FOLFIRI Regimen
      Jae Hyun Kim, Pyoung Rak Choi, Seun Ja Park, Moo In Park, Won Moon, Sung Eun Kim, Gyu Won Lee
      The Korean Journal of Gastroenterology.2014; 63(4): 209.     CrossRef
    • A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
      Y-K Kang, S Y Rha, P Tassone, J Barriuso, R Yu, T Szado, A Garg, Y-J Bang
      British Journal of Cancer.2014; 111(4): 660.     CrossRef
    • Body mass index and biliary tract disease: A systematic review and meta-analysis of prospective studies
      Myungsook Park, Da Young Song, Youjin Je, Jung Eun Lee
      Preventive Medicine.2014; 65: 13.     CrossRef
    • The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database
      Zisun Kim, Sun Young Min, Chan Seok Yoon, Hun Jae Lee, Jung Sun Lee, Hyun Jo Youn, Heung Kyu Park, Dong-Young Noh, Min Hee Hur
      Journal of Breast Cancer.2014; 17(2): 99.     CrossRef
    • OLGA and OLGIM Stage Distribution According to Age and Helicobacter pylori Status in the Korean Population
      Ji Hyung Nam, Il Ju Choi, Myeong‐Cherl Kook, Jong Yeul Lee, Soo‐Jeong Cho, Su Youn Nam, Chan Gyoo Kim
      Helicobacter.2014; 19(2): 81.     CrossRef
    • Clinical Outcomes of CyberKnife Radiotherapy in Prostate Cancer Patients: Short-term, Single-Center Experience
      Dong-Hoon Koh, Jin-Bum Kim, Hong-Wook Kim, Young-Seop Chang, Hyung Joon Kim
      Korean Journal of Urology.2014; 55(3): 172.     CrossRef
    • Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell
      Dong-Guk Park
      Annals of Surgical Treatment and Research.2014; 86(2): 68.     CrossRef
    • Long-Term Oncologic Outcomes after Radical Cystectomy for Bladder Cancer at a Single Institution
      Taekmin Kwon, In Gab Jeong, Dalsan You, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
      Journal of Korean Medical Science.2014; 29(5): 669.     CrossRef
    • Clinical profiles of multiple myeloma in Asia—An Asian Myeloma Network study
      Kihyun Kim, Jae Hoon Lee, Jin Seok Kim, Chang Ki Min, Sung Soo Yoon, Kazuyuki Shimizu, Takaaki Chou, Hiroshi Kosugi, Kenshi Suzuki, Wenming Chen, Jian Hou, Jin Lu, Xiao‐Jun Huang, Shang‐Yi Huang, Wee Joo Chng, Daryl Tan, Gerrard Teoh, Chor Sang Chim, Weer
      American Journal of Hematology.2014; 89(7): 751.     CrossRef
    • Clinicopathological Characteristics of Newly Diagnosed Colorectal Cancers in Community Gastroenterology Practice
      Chang Kyun Lee
      Intestinal Research.2014; 12(2): 87.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2014
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Duk Hyoung Lee, Jin Soo Lee
      Cancer Research and Treatment.2014; 46(2): 124.     CrossRef
    • Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma
      Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
      The Korean Journal of Gastroenterology.2014; 63(5): 292.     CrossRef
    • Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors
      Aera Yoon, Chel Hun Choi, Tae-Hyun Kim, June-Kuk Choi, Jin-Young Park, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
      International Journal of Gynecological Cancer.2014; 24(1): 107.     CrossRef
    • Long‐term outcomes after fertility‐sparing laparoscopic radical trachelectomy in young women with early‐stage cervical cancer: An Asan Gynecologic Cancer Group (AGCG) study
      Jeong‐Yeol Park, Won Deok Joo, Suk‐Joon Chang, Dae‐Yeon Kim, Jong‐Hyeok Kim, Yong‐Man Kim, Young‐Tak Kim, Joo‐Hyun Nam
      Journal of Surgical Oncology.2014; 110(3): 252.     CrossRef
    • FOLFIRI as Second-line Chemotherapy after Failure of FOLFOX4 in Advanced Colorectal Cancer: A Korean Single-center Experience
      Jae Hyun Kim, Seun Ja Park, Moo In Park, Won Moon, Sung Eun Kim, Ki Hwan Ku, Sung Eun Song, Je Hun Kim
      The Korean Journal of Gastroenterology.2014; 63(1): 18.     CrossRef
    • A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
      Young Saing Kim, Sun Jin Sym, Se Hoon Park, Inkeun Park, Junshik Hong, Hee Kyung Ahn, Jinny Park, Eun Kyung Cho, Woon Ki Lee, Min Chung, Jae Hoon Lee, Dong Bok Shin
      Cancer Chemotherapy and Pharmacology.2014; 73(1): 163.     CrossRef
    • S100 expression in dendritic cells is inversely correlated with tumor grade in endometrial carcinoma
      Young Joo Lee, Sun Young Kang, Moo Sung Jo, Dong Soo Suh, Ki Hyung Kim, Man Soo Yoon
      Obstetrics & Gynecology Science.2014; 57(3): 201.     CrossRef
    • Lower extremity edema in patients with early ovarian cancer
      Myong Lim, Jeong Lee, Byung Nam, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park
      Journal of Ovarian Research.2014; 7(1): 28.     CrossRef
    • Reproductive outcomes after laparoscopic radical trachelectomy for early-stage cervical cancer
      Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      Journal of Gynecologic Oncology.2014; 25(1): 9.     CrossRef
    • Nonmetastatic Castration-Resistant Prostate Cancer
      Jun Hyuk Hong, Isaac Y. Kim
      Korean Journal of Urology.2014; 55(3): 153.     CrossRef
    • The effectiveness of gadolinium MRI to improve target delineation for radiotherapy in hepatocellular carcinoma: A comparative study of rigid image registration techniques
      D.S. Yang, W.S. Yoon, J.A. Lee, N.K. Lee, S. Lee, C.Y. Kim, H.J. Yim, S.H. Lee, H.H. Chung, S.H. Cha
      Physica Medica.2014; 30(6): 676.     CrossRef
    • Laparoendoscopic Single-Site Versus Conventional Laparoscopic Surgical Staging for Early-Stage Endometrial Cancer
      Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Joo-Hyun Nam
      International Journal of Gynecological Cancer.2014; 24(2): 358.     CrossRef
    • A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant ActivatingEGFRMutation andROS1Rearrangement
      Min Hwan Kim, Yehyun Park, Hye Jung Park, Ah-young Ji, Changho Song, Moo-Nyun Jin, Young Ju Kim, Sun Wook Kim, Jung-Hee Lee, In-Soo Kim, Hye Ryun Kim, Joohang Kim, Byoung Chul Cho
      The Ewha Medical Journal.2014; 37(1): 46.     CrossRef
    • Postoperative radiotherapy dose correlates with locoregional control in patients with extra-hepatic bile duct cancer
      Jung Ho Im, Jinsil Seong, Jeongshim Lee, Yong Bae Kim, Ik Jae Lee, Jun Sung Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee
      Radiation Oncology Journal.2014; 32(1): 7.     CrossRef
    • Utility of Second-Look Examinations in the Management of a New Hypermetabolic Lesion Detected by Fluorodeoxyglucose Positron Emission Tomography/CT for Diagnosis of Loco-Regional Recurrence in Patients with Breast Cancer
      Jinyoung Park, Kyu Ran Cho, Eun Kyung Park, Bo Kyoung Seo, Ok Hee Woo, Sung Eun Song, Yu Whan Oh, Jeong Won Bae
      Journal of the Korean Society of Radiology.2014; 70(2): 145.     CrossRef
    • Health-related Quality of Life Among Cancer Survivors in Korea: The Korea National Health and Nutrition Examination Survey
      M. G. Oh, M. A. Han, C.-Y. Park, S.-G. Park, C. H. Chung
      Japanese Journal of Clinical Oncology.2014; 44(2): 153.     CrossRef
    • Risk Factors of Colon Polyps in Colonoscopy Examinee
      Bok Hee Park, Yun Mi Lee
      Journal of Korean Biological Nursing Science.2014; 16(1): 33.     CrossRef
    • Preoperative Thrombocytosis Is an Independent Poor Prognostic Factor in Patients with Epithelial Ovarian Cancer
      Jisu Oh, Min Chul Choi, Hyun Park, Chan Lee, Jun Mo Lee, So Young Chong, Doyeun Oh
      Clinical & Experimental Thrombosis and Hemostasis.2014; 1(1): 17.     CrossRef
    • Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
      Kyongchol Kim, Dong Gue Shin, Min Koo Park, Seung Hyuk Baik, Tae Hee Kim, Sanghee Kim, SaeYoung Lee
      Annals of Surgical Treatment and Research.2014; 86(3): 136.     CrossRef
    • Impact of body mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: A cohort study
      Jeong-Yeol Park, Jae-Hyun Cho, Jin-Young Min, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      Obstetrics & Gynecology Science.2014; 57(2): 115.     CrossRef
    • Circulating Concentrations of C-Peptide and Colorectal Adenoma
      Yoon Ji Choi, Young Ha Kim, Chang Ho Cho, Sung Hi Kim, Jung Eun Lee
      Clinical Nutrition Research.2014; 3(1): 17.     CrossRef
    • The Effect of Body Mass Index on Survival in Advanced Epithelial Ovarian Cancer
      Hyo Sook Bae, Jin Hwa Hong, Kyoung-Do Ki, Jae Yun Song, Jin Woo Shin, Jong Min Lee, Jae Kwan Lee, Nak Woo Lee, Chan Lee, Kyu Wan Lee, Yong Min Kim
      Journal of Korean Medical Science.2014; 29(6): 793.     CrossRef
    • Red meat consumption is associated with an increased overall cancer risk: a prospective cohort study in Korea
      Gyung-Ah Wie, Yeong-Ah Cho, Hyun-hee Kang, Kyoung-A Ryu, Min-Kyoung Yoo, Young-A Kim, Kyu-Won Jung, Jeongseon Kim, Joo-Hyuk Lee, Hyojee Joung
      British Journal of Nutrition.2014; 112(2): 238.     CrossRef
    • Helicobacter pylori Recurrence after First‐ and Second‐Line Eradication Therapy in Korea: The Problem of Recrudescence or Reinfection
      Seung Young Kim, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Hyung Joon Yim, Sang Woo Lee
      Helicobacter.2014; 19(3): 202.     CrossRef
    • A Case of Successful Endoscopic Clipping for Iatrogenic Colon Perforation Induced by Peritoneal Catheter Insertion
      Kyu Yeon Hahn, Hyun Ju Kim, Hye Jung Park, Sun Wook Kim, Soo Yun Chang, Beom Kyung Kim, Kwang Hyub Han, Sung Pil Hong
      The Korean Journal of Gastroenterology.2014; 63(6): 373.     CrossRef
    • A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1–2 glottic squamous cell carcinomas: Results of a Korean Radiation Oncology Group (KROG-0201) study
      Sung Ho Moon, Kwan Ho Cho, Eun Ji Chung, Chang Geol Lee, Kyu Chan Lee, Gyu-Young Chai, Ki Mun Kang, Jong Young Lee, Woong-Ki Chung, Woo Yoon Park, Jin Hee Kim
      Radiotherapy and Oncology.2014; 110(1): 98.     CrossRef
    • Dietary Intake Status among Korean Female Breast Cancer Survivors
      Myungsook Park, Eunkyung Hwang, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
      Korean Journal of Community Nutrition.2014; 19(2): 163.     CrossRef
    • Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB–IV lung cancer patients
      Yu Jung Kim, Mi-Jung Kim, Young-Jae Cho, Jong Sun Park, Jin Won Kim, Hyun Chang, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Ho Il Yoon, Soo-Mee Bang, Jae Ho Lee, Choon-Taek Lee, Jong Seok Lee
      Medical Oncology.2014;[Epub]     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Duk Hyoung Lee, Jin Soo Lee
      Cancer Research and Treatment.2014; 46(2): 109.     CrossRef
    • Clinical Usefulness of 18F-Fluorodeoxyglucose-Positron Emission Tomography in Patients With Locally Advanced Pancreatic Cancer Planned to Undergo Concurrent Chemoradiation Therapy
      Jee Suk Chang, Seo Hee Choi, Youngin Lee, Kyung Hwan Kim, Jeong Youp Park, Si Young Song, Arthur Cho, Mijin Yun, Jong Doo Lee, Jinsil Seong
      International Journal of Radiation Oncology*Biology*Physics.2014; 90(1): 126.     CrossRef
    • The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: A case-control study
      Kyong-Hwa Jun, Jeong-Sun Lee, Ji-Hyun Kim, Jin-Jo Kim, Hyung-Min Chin, Seung-Man Park
      International Journal of Surgery.2014; 12(9): 893.     CrossRef
    • Trends in gynecologic cancer mortality in East Asian regions
      Jung-Yun Lee, Eun-Yang Kim, Kyu-Won Jung, Aesun Shin, Karen K. L. Chan, Daisuke Aoki, Jae-Weon Kim, Jeffrey J. H. Low, Young-Joo Won
      Journal of Gynecologic Oncology.2014; 25(3): 174.     CrossRef
    • Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases
      Jun Su Park, Hee Chul Park, Doo Ho Choi, Won Park, Jeong Il Yu, Young Suk Park, Won Ki Kang, Joon Oh Park
      Radiation Oncology Journal.2014; 32(2): 77.     CrossRef
    • Comparison of Short-Term Postoperative Outcomes in Totally Laparoscopic Distal Gastrectomy Versus Laparoscopy-Assisted Distal Gastrectomy
      Gru Han, Ji Yeon Park, Yong Jin Kim
      Journal of Gastric Cancer.2014; 14(2): 105.     CrossRef
    • Impact of Hyperglycemia on Survival and Infection-Related Adverse Events in Patients with Metastatic Colorectal Cancer Who Were Receiving Palliative Chemotherapy
      Yong Joo Hong, Hye-Suk Han, Yusook Jeong, Jiwon Jeong, Sung-Nam Lim, Hyung Jin Choi, Hyun-Jung Jeon, Tae-Keun Oh, Sang-Jeon Lee, Ki Hyeong Lee
      Cancer Research and Treatment.2014; 46(3): 288.     CrossRef
    • Long-Term Survival Analysis of Korean Breast Cancer Patients at a Single Center: Improving Outcome Over Time
      Sung Gwe Ahn, Hak Min Lee, Seung Ah Lee, Joon Jeong, Hy-De Lee
      Yonsei Medical Journal.2014; 55(5): 1187.     CrossRef
    • Low virulence? Clinical characteristics of Raoultella planticola bacteremia
      S. Chun, J. W. Yun, H. J. Huh, N. Y. Lee
      Infection.2014; 42(5): 899.     CrossRef
    • Prognostic stratification of brain metastases from hepatocellular carcinoma
      Kyung Su Kim, Kyubo Kim, Eui Kyu Chie, Yoon Jun Kim, Jung Hwan Yoon, Hyo-Suk Lee, Sung W. Ha
      Journal of Neuro-Oncology.2014; 120(1): 209.     CrossRef
    • Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma
      In Kook Jung, Sun Sook Kim, Dong Soo Suh, Ki Hyung Kim, Chang Hoon Lee, Man Soo Yoon
      Obstetrics & Gynecology Science.2014; 57(4): 266.     CrossRef
    • Tumor SUVmax Normalized to Liver Uptake on 18F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
      Jihyun Park, Kyoung Jin Chang, Young Seok Seo, Byung Hyun Byun, Joon Ho Choi, Hansol Moon, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Sang Moo Lim
      Nuclear Medicine and Molecular Imaging.2014; 48(4): 295.     CrossRef
    • Cancer Control Programs in East Asia: Evidence From the International Literature
      Malcolm A. Moore
      Journal of Preventive Medicine & Public Health.2014; 47(4): 183.     CrossRef
    • Abiraterone acetate and prednisolone for metastatic castration‐resistant prostate cancer failing androgen deprivation and docetaxel‐based chemotherapy: A phase II bridging study in Korean and Taiwanese patients
      Cheol Kwak, Tony Tong Lin Wu, Hyun Moo Lee, Hsi Chin Wu, Sung Joon Hong, Yen Chuan Ou, Seok Soo Byun, Hyou Young Rhim, Thian Kheoh, Ying Wan, Howard Yeh, Margaret K Yu, Choung Soo Kim
      International Journal of Urology.2014; 21(12): 1239.     CrossRef
    • Dietary Factors and the Risk of Thyroid Cancer: A Review
      Wook Jin Choi, Jeongseon Kim
      Clinical Nutrition Research.2014; 3(2): 75.     CrossRef
    • Clinical Outcomes of the Endoscopic Treatments for the Early Esophageal Carcinoma and Dysplasia
      Cheol Kim, Su Jin Hong, Jae Pil Han, Hee Jae Jung, Eun Soo Jeong, Hyeon Jeong Goong, Heejun Kim, Seoung Ho Lee, Bong Min Ko, Moon Sung Lee
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2014; 14(3): 187.     CrossRef
    • Small bowel diverticulosis in patient with early gastric cancer
      Pyeong Su Kim, Eun-Joo Jung, Ho Yoon Bang
      Annals of Surgical Treatment and Research.2014; 87(4): 209.     CrossRef
    • Discovery of Melanotransferrin as a Serological Marker of Colorectal Cancer by Secretome Analysis and Quantitative Proteomics
      Jihye Shin, Hye-Jung Kim, Gamin Kim, Meiying Song, Se Joon Woo, Seung-Taek Lee, Hoguen Kim, Cheolju Lee
      Journal of Proteome Research.2014; 13(11): 4919.     CrossRef
    • Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer
      Jung Il Son, Sang Youl Rhee, Jeong-taek Woo, Won Seo Park, Jong Kyu Byun, Yu-Jin Kim, Ja Min Byun, Sang Ouk Chin, Suk Chon, Seungjoon Oh, Sung Woon Kim, Young Seol Kim
      Endocrinology and Metabolism.2014; 29(3): 293.     CrossRef
    • The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer
      Hyo Chun Lee, Yeon Sil Kim, Se Jin Oh, Yun Hee Lee, Dong Soo Lee, Jin Ho Song, Jin Hyung Kang, Jae Kil Park
      Radiation Oncology Journal.2014; 32(3): 147.     CrossRef
    • Outcome of postoperative radiotherapy following radical prostatectomy: a single institutional experience
      Sea-Won Lee, Tae-Kon Hwang, Sung-Hoo Hong, Ji-Youl Lee, Mi Joo Chung, Song Mi Jeong, Sung Hwan Kim, Jong Hoon Lee, Hong Seok Jang, Sei Chul Yoon
      Radiation Oncology Journal.2014; 32(3): 138.     CrossRef
    • Secular trends in the prognostic factors for papillary thyroid cancer
      Hoonsung Choi, Jung Ah Lim, Hwa Young Ahn, Sun Wook Cho, Kyu Eun Lee, Kyung Won Kim, Ka Hee Yi, Myung-Whun Sung, Yeo-Kyu Youn, June-Key Chung, Young Joo Park, Do Joon Park, Bo Youn Cho
      European Journal of Endocrinology.2014; 171(5): 667.     CrossRef
    • Epidemiological and Genome-Wide Association Study of Gastritis or Gastric Ulcer in Korean Populations
      Sumin Oh, Sejong Oh
      Genomics & Informatics.2014; 12(3): 127.     CrossRef
    • Estimated Amount of 24-Hour Urine Sodium Excretion Is Positively Correlated with Stomach and Breast Cancer Prevalence in Korea
      Jung Hwan Park, Yong Chul Kim, Ho Seok Koo, Se Won Oh, Suhnggwon Kim, Ho Jun Chin
      Journal of Korean Medical Science.2014; 29(Suppl 2): S131.     CrossRef
    • Completeness of pedigree and family cancer history for ovarian cancer patients
      Yedong Son, Myong Cheol Lim, Sang Soo Seo, Sokbom Kang, Sang-Yoon Park
      Journal of Gynecologic Oncology.2014; 25(4): 342.     CrossRef
    • Risk of Chronic Kidney Disease After Nephrectomy for Renal Cell Carcinoma
      Seung-Kwon Choi, Cheryn Song
      Korean Journal of Urology.2014; 55(10): 636.     CrossRef
    • The Challenges Faced by the Korean Society for Radiation Oncology in the National Healthcare System in Korea
      Kwan Ho Cho
      International Journal of Radiation Oncology*Biology*Physics.2014; 90(4): 725.     CrossRef
    • Factors influencing Korean nurses’ attitudes towards hospice care
      K.S. Park, H.A. Yeom
      International Nursing Review.2014; 61(4): 563.     CrossRef
    • Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B Carriers
      Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun
      Medicine.2014; 93(20): e91.     CrossRef
    • The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
      Moo Hyun Lee, Wonshik Han, Jeong Eon Lee, Ku Sang Kim, Heeseung Park, Jongjin Kim, Soo Youn Bae, Hyun Joo Shin, Jong Won Lee, Eun Sook Lee
      Cancer Research and Treatment.2014; 47(2): 208.     CrossRef
    • Correlations Among Endoscopic, Histologic and Serologic Diagnoses for the Assessment of Atrophic Gastritis
      Ju Yup Lee, Nayoung Kim, Hye Seung Lee, Jane C. Oh, Yong Hwan Kwon, Yoon Jin Choi, Ki Chul Yoon, Jae Jin Hwang, Hyun Joo Lee, AeRa Lee, Yeonsang Jeong, Hyun Jin Jo, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
      Journal of Cancer Prevention.2014; 19(1): 47.     CrossRef
    • Epidemiologic Characteristics of Compensated Occupational Lung Cancers among Korean Workers
      Yeon-Soon Ahn, Kyoung Sook Jeong
      Journal of Korean Medical Science.2014; 29(11): 1473.     CrossRef
    • Copayment Policy Effects on Healthcare Spending and Utilization by Korean Lung Cancer Patients at End of Life: A Retrospective Cohort Design 2003-2012
      Sun Jung Kim, Kyu-Tae Han, Eun-Cheol Park, Sohee Park, Tae Hyun Kim
      Asian Pacific Journal of Cancer Prevention.2014; 15(13): 5265.     CrossRef
    • Identification of Major Nursing Diagnosis, Nursing Outcomes, and Nursing Interventions (NNN) Linkage for Cancer Patients Undergoing Chemotherapy
      Su Mi Song, Hyangsook So, Minjeong An
      Korean Journal of Adult Nursing.2014; 26(4): 413.     CrossRef
    • Alcohol Intake, Smoking, and Colorectal Adenoma
      Yeong Mi Park, Chang Ho Cho, Sung Hi Kim, Jung Eun Lee
      Journal of Cancer Prevention.2014; 19(2): 137.     CrossRef
    • Preliminary Evaluation of Clinical Utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in Stomach Cancer
      Hee Keun Gwak, Jai Hyuen Lee, Seok Gun Park
      Asian Pacific Journal of Cancer Prevention.2014; 15(12): 4933.     CrossRef
    • Effectiveness of Ultrasonographic Screening for Thyroid Cancer: Round-table Conference in the National Evidence-based Healthcare Collaborating Agency (NECA) in conjunction with the Korean Thyroid Association
      Sangjin Shin, Sae Eun Park, Soo Young Kim, Min Kyung Hyun, Sun Wook Kim, Jin Won Kwon, Yeol Kim, Won Bae Kim, Dong Gyu Na, Hyun-Ah Park, Seung Soo Sheen, Ka Hee Yi, Hang-Seok Chang, Jung Jin Cho, Jae Hoon Chung
      Asian Pacific Journal of Cancer Prevention.2014; 15(12): 5107.     CrossRef
    • Validation of the Prognosis in Palliative Care Study Predictor Models in Terminal Cancer Patients
      Eun-Shin Kim, Jung-Kwon Lee, Mi-Hyun Kim, Hye-Mi Noh, Yeong-Hyeon Jin
      Korean Journal of Family Medicine.2014; 35(6): 283.     CrossRef
    • A Framework for Estimating Radiation-Related Cancer Risks in Japan from the 2011 Fukushima Nuclear Accident
      L. Walsh, W. Zhang, R. E. Shore, A. Auvinen, D. Laurier, R. Wakeford, P. Jacob, N. Gent, L. R. Anspaugh, J. Schüz, A. Kesminiene, E. van Deventer, A. Tritscher, M. del Rosarion Pérez
      Radiation Research.2014; 182(5): 556.     CrossRef
    • Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach
      Bumsoo Park, Seol Ho Choo, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi
      Journal of Korean Medical Science.2014; 29(12): 1688.     CrossRef
    • Setting a Health Policy Research Agenda for Controlling Cancer Burden in Korea
      Sung-In Jang, Kyoung-Hee Cho, Sun Jung Kim, Kwang-Sig Lee, Eun-Cheol Park
      Cancer Research and Treatment.2014; 47(2): 149.     CrossRef
    • Screening for Gastric Cancer: The Usefulness of Endoscopy
      Kui Son Choi, Mina Suh
      Clinical Endoscopy.2014; 47(6): 490.     CrossRef
    • The effect of changing stool collection processes on compliance in nationwide organized screening using a fecal occult blood test (FOBT) in Korea: study protocol for a randomized controlled trial
      Hye Young Shin, Mina Suh, Hyung Won Baik, Kui Son Choi, Boyoung Park, Jae Kwan Jun, Chan Wha Lee, Jae Hwan Oh, You Kyoung Lee, Dong Soo Han, Do-Hoon Lee
      Trials.2014;[Epub]     CrossRef
    • Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer Patients
      Jung Sun Kim, In Hae Park, Keun Seok Lee, Jungsil Ro
      Journal of Breast Cancer.2014; 17(4): 339.     CrossRef
    • Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
      Yun Mi Choi, Tae Yong Kim, Eun Kyung Jang, Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
      Endocrinology and Metabolism.2014; 29(4): 530.     CrossRef
    • Long-Term Outcomes of Proximal Gastrectomy versus Total Gastrectomy for Upper-Third Gastric Cancer
      Myoung Won Son, Yong Jin Kim, Gui Ae Jeong, Gyu Seok Cho, Moon Soo Lee
      Journal of Gastric Cancer.2014; 14(4): 246.     CrossRef
    • Economic Evaluation of Prostate Cancer Screening Test as a National Cancer Screening Program in South Korea
      Sangjin Shin, Youn Hee Kim, Jin Sub Hwang, Yoon Jae Lee, Sang Moo Lee, Jeonghoon Ahn
      Asian Pacific Journal of Cancer Prevention.2014; 15(8): 3383.     CrossRef
    • Correlation of Breast Cancer Incidence with the Number of Motor Vehicles and Consumption of Gasoline in Korea
      Boyoung Park, Aesun Shin, Kyunghee Jung-Choi, Eunhee Ha, Hae-Kwan Cheong, Hyun Jeong Kim, Kyung Hwa Park, Sungmi Jang, Byung-In Moon, Mina Ha
      Asian Pacific Journal of Cancer Prevention.2014; 15(7): 2959.     CrossRef
    • Barriers to Cancer Screening among Medical Aid Program Recipients in the Republic of Korea: A Qualitative Study
      Yoon Young Lee, Jae Kwan Jun, Mina Suh, BoYoung Park, Yeol Kim, Kui Son Choi
      Asian Pacific Journal of Cancer Prevention.2014; 15(2): 589.     CrossRef
    • Female Breast Cancer Incidence and Mortality in Mexico, 2000-2010
      Maricruz Anaya-Ruiz, Veronica Vallejo-Ruiz, Lilian Flores-Mendoza, Martin Perez-Santos
      Asian Pacific Journal of Cancer Prevention.2014; 15(3): 1477.     CrossRef
    • Which Patients Should We Follow up beyond 5 Years after Definitive Therapy for Localized Renal Cell Carcinoma?
      Sang Hyub Lee, Hee Seo Son, Seok Cho, Sang Jin Kim, Dae Seon Yoo, Seok Ho Kang, Sung Yul Park, Jinsung Park, Sung-Goo Chang, Seung Hyun Jeon
      Cancer Research and Treatment.2014; 47(3): 489.     CrossRef
    • Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea
      Chang-Mo Oh, Kyu-Won Jung, Young-Joo Won, Aesun Shin, Hyun-Joo Kong, Jin-Soo Lee
      Cancer Research and Treatment.2014; 47(3): 362.     CrossRef
    • Economic Burden of Cancer in Korea during 2000-2010
      Kwang-Sig Lee, Hoo-Sun Chang, Sun-Mi Lee, Eun-Cheol Park
      Cancer Research and Treatment.2014; 47(3): 387.     CrossRef
    • Exercise Barriers in Korean Colorectal Cancer Patients
      Dong-Woo Kang, Jae Youn Chung, Mi Kyung Lee, Junga Lee, Ji-Hye Park, Dong-Il Kim, Lee W. Jones, Joong Bae Ahn, Nam Kyu Kim, Justin Y. Jeon
      Asian Pacific Journal of Cancer Prevention.2014; 15(18): 7539.     CrossRef
    • Thyroid Gland Evaluation of Adults in Their 20s by means of a Screening Ultrasound Test and a Self-Test
      TaeJeong Ji
      The Journal of the Korea Contents Association.2014; 14(11): 347.     CrossRef
    • The relation between comprehensive health needs of cancer patient and the quality of life
      Hyung-Won Baik, Myung Kim
      Journal of Digital Convergence.2014; 12(12): 477.     CrossRef
    • Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-II Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis
      Jong Hoon Lee, Hyo Chun Lee, Sung Hwan Kim, Mi Joo Chung, Song Mi Jeong, Sung Jong Lee, Joo Hee Yoon, Dong Choon Park
      Cancer Research and Treatment.2014; 47(2): 298.     CrossRef
    • Effect of Short-Term Hypothyroid State on Lipid Profile and Cardiovascular Risk Markers in Subjects Preparing Radioactive Iodine Therapy
      Hye Ju Yeo, A Ra Jo, Hye Won Lee, Dong Won Yi, Yang Ho Kang, Seok Man Son
      Journal of Korean Thyroid Association.2014; 7(2): 172.     CrossRef
    • Comparison of Diabetes Management Status between Cancer Survivors and the General Population: Results from a Korean Population-Based Survey
      Ji-Yeon Shin, Hye Young Shim, Jae Kwan Jun, Andrea Icks
      PLoS ONE.2014; 9(10): e110412.     CrossRef
    • Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
      Hee Kyung Kim, Ji Shin Lee, Min Ho Park, Jin Seong Cho, Jee Hee Yoon, Soo Jeong Kim, Ho-Cheol Kang, Rafael Rosell
      PLoS ONE.2014; 9(10): e110241.     CrossRef
    • Cancer Incidence and Survival among Adolescents and Young Adults in Korea
      Eun-Kyeong Moon, Hyeon Jin Park, Chang-Mo Oh, Kyu-Won Jung, Hee Young Shin, Byung Kiu Park, Young-Joo Won, Bart O. Williams
      PLoS ONE.2014; 9(5): e96088.     CrossRef
    • Knowledge, Practices, and Perceived Barriers Regarding Cancer Pain Management Among Physicians and Nurses In Korea: A Nationwide Multicenter Survey
      Hyun Jung Jho, Yeol Kim, Kyung Ae Kong, Dae Hyun Kim, Jin Young Choi, Eun Jeong Nam, Jin Young Choi, Sujin Koh, Kwan Ok Hwang, Sun Kyung Baek, Eun Jung Park, Richard E. Burney
      PLoS ONE.2014; 9(8): e105900.     CrossRef
    • The Associations between Immunity-Related Genes and Breast Cancer Prognosis in Korean Women
      Jaesung Choi, Nan Song, Sohee Han, Seokang Chung, Hyuna Sung, Ji-young Lee, Sunjae Jung, Sue K. Park, Keun-Young Yoo, Wonshik Han, Jong Won Lee, Dong-Young Noh, Daehee Kang, Ji-Yeob Choi, Masaru Katoh
      PLoS ONE.2014; 9(7): e103593.     CrossRef
    • Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men
      Chang Wook Jeong, Sangchul Lee, Jin-Woo Jung, Byung Ki Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee, Adriano Angelucci
      PLoS ONE.2014; 9(4): e94441.     CrossRef
    • Multifactorial, Site-Specific Recurrence Models after Radical Cystectomy for Urothelial Carcinoma: External Validation in a Cohort of Korean Patients
      Hyung Suk Kim, Myong Kim, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku, Bart O. Williams
      PLoS ONE.2014; 9(6): e100491.     CrossRef
    • Increased Prevalence of Chronic Lymphocytic Thyroiditis in Korean Patients with Papillary Thyroid Cancer
      Chang-Mo Oh, Sohee Park, Joo Young Lee, Young-Joo Won, Aesun Shin, Hyun-Joo Kong, Kui-Sun Choi, You Jin Lee, Ki- Wook Chung, Kyu-Won Jung, Jeffrey S. Chang
      PLoS ONE.2014; 9(6): e99054.     CrossRef
    • Corosolic acid induces apoptotic cell death in HCT116 human colon cancer cells through a caspase-dependent pathway
      BOKYUNG SUNG, YONG JUNG KANG, DONG HWAN KIM, SEONG YEON HWANG, YUJIN LEE, MINJEONG KIM, JEONG-HYUN YOON, CHEOL MIN KIM, HAE YOUNG CHUNG, NAM DEUK KIM
      International Journal of Molecular Medicine.2014; 33(4): 943.     CrossRef
    • Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer
      HEE JIN SO, SEOK-IL HONG, JIN KYUNG LEE, YOON HWAN CHANG, SUN JUNG KANG, YOUNG JUN HONG
      Biomedical Reports.2014; 2(5): 737.     CrossRef
    • Smoking Cessation for Cancer Survivors
      Eon Sook Lee, Cheol Min Lee, Yooseok Cheong
      Journal of the Korean Society for Research on Nicotine and Tobacco.2014; 5(2): 63.     CrossRef
    • Salvage Treatment with Low-Dose Weekly Paclitaxel in Elderly or Poor Performance Status Patients with Metastatic Urothelial Carcinoma
      Jae Joon Han, Yu Jung Kim, Jin Won Kim, Hyun Chang, Jeong-Ok Lee, Keun-Wook Lee, Chang Wook Jeong, Jee Hyun Kim, Sung Kyu Hong, Soo-Mee Bang, Seok-Soo Byun, Sang Eun Lee, Jong Seok Lee
      Tumori Journal.2014; 100(4): 439.     CrossRef
    • Childhood Height and Body Mass Index Were Associated with Risk of Adult Thyroid Cancer in a Large Cohort Study
      Cari M. Kitahara, Michael Gamborg, Amy Berrington de González, Thorkild I.A. Sørensen, Jennifer L. Baker
      Cancer Research.2014; 74(1): 235.     CrossRef
    • Comparison on colonoscopic parameters according to length of adult-colonoscope
      Lee Seung-Hwa, Lee Duck-Joo
      Chinese Medical Journal.2014; 127(1): 85.     CrossRef
    • Genomic Profiling of Liver Cancer
      Ju-Seog Lee
      Genomics & Informatics.2013; 11(4): 180.     CrossRef
    • Recent advances in the management of hepatocellular carcinoma
      Hee Chul Park
      Journal of the Korean Medical Association.2013; 56(11): 946.     CrossRef
    • Viral Hepatitis and Liver Cancer in Korea: an Epidemiological Perspective
      Yohwan Yeo, Jin Gwack, Seokin Kang, Boyeon Koo, Sun Jae Jung, Prakash Dhamala, Kwang-Pil Ko, Young-Khi Lim, Keun-Young Yoo
      Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6227.     CrossRef
    • A Comparison of the Recovery Characteristics between Propofol-remifentil and Sevoflurane-remifentail Anesthesia for Total Thyroidectomy
      Dong Hee Kang, Jeong Gil Lee, Hyeong Ju Jung, Ju Deok Kim, Soo Bong Yu, Si Jeong Ryu, Gyeong Han Kim, Doo Sik Kim
      Kosin Medical Journal.2013; 28(2): 137.     CrossRef
    • [6]-Gingerol Prevents Disassembly of Cell Junctions and Activities of MMPs in Invasive Human Pancreas Cancer Cells through ERK/NF-κB/Snail Signal Transduction Pathway
      Sung Ok Kim, Mi Ryeo Kim
      Evidence-Based Complementary and Alternative Medicine.2013; 2013: 1.     CrossRef
    • ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
      Cheol Lee, Jeong Whan Park, Ja Hee Suh, Kyung Han Nam, Kyung Chul Moon
      Korean Journal of Pathology.2013; 47(5): 452.     CrossRef
    • Noncommunicable Diseases: Current Status of Major Modifiable Risk Factors in Korea
      Hyeon Chang Kim, Sun Min Oh
      Journal of Preventive Medicine & Public Health.2013; 46(4): 165.     CrossRef
    • Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location
      J M Bae, J H Kim, N-Y Cho, T-Y Kim, G H Kang
      British Journal of Cancer.2013; 109(4): 1004.     CrossRef
    • Investigation of Clinical Manifestations in Korean Colorectal Cancer Patients
      Hye Young Koo, Kyu Joo Park, Jae Hwan Oh, Sung Bum Kang, Seong Taek Oh, Woo Yong Lee
      Annals of Coloproctology.2013; 29(4): 139.     CrossRef
    • Relationship between Social Network and Stage of Adoption of Gastric Cancer Screening among the Korean Population
      Myung Ha Lee, Kui Son Choi, Yoon Young Lee, Mina Suh, Jae Kwan Jun
      Asian Pacific Journal of Cancer Prevention.2013; 14(10): 6095.     CrossRef
    • Death Perceptions, Death Anxiety, and Attitudes to Death in Oncology Nurses
      Eunmi Hong, Meeduk Jun, Eun Shim Park, Eunjung Ryu
      Asian Oncology Nursing.2013; 13(4): 265.     CrossRef
    • Flavonoids from Orostachys japonicus A. Berger Inhibit the Invasion of LnCaP Prostate Carcinoma Cells by Inactivating Akt and Modulating Tight Junctions
      Dong Shin, Won Lee, Ji Jung, Su Hong, Cheol Park, Hye Kim, Gi-Young Kim, Hye Hwang, Gon Kim, Jin-Myung Jung, Chung Ryu, Sung Shin, Soon Hong, Yung Choi
      International Journal of Molecular Sciences.2013; 14(9): 18407.     CrossRef
    • Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data
      Hyoung-Chul Park, Kyu-Won Jung, Byung-Woo Kim, Aesun Shin, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
      Annals of Coloproctology.2013; 29(5): 182.     CrossRef
    • Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis
      H.S. Kim, H.J. Kim, S.Y. Kim, T.Y. Kim, K.W. Lee, S.K. Baek, T.Y. Kim, M.H. Ryu, B.H. Nam, D.Y. Zang
      Annals of Oncology.2013; 24(11): 2850.     CrossRef
    • A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma
      Sunmi Jo, Hye Kyung Shim
      Radiation Oncology Journal.2013; 31(4): 267.     CrossRef
    • Association of body mass index and postoperative outcome in patients with colorectal cancer
      Tae Wan Lim, Byung Eun Yoo, Jae Won Shin, Dong Won Lee, Jung Myun Kwak, Jin Kim, Seon Hahn Kim
      Korean Journal of Clinical Oncology.2013; 9(2): 87.     CrossRef
    • The Association Between the Socioeconomic Status and Thyroid Cancer Prevalence; Based on the Korean National Health and Nutrition Examination Survey 2010-2011
      Seong-Woo Choi, So-Yeon Ryu, Mi-ah Han, Jong Park
      Journal of Korean Medical Science.2013; 28(12): 1734.     CrossRef
    • Added Value of Magnetic Resonance Imaging in Staging of Malignant Pleural Mesothelioma
      Eunsol Lee, Eun Jin Chae, Sunji Kang, Yoo Kyeong Yeom, Hyun Joo Lee, Jong Chun Park, So Youn Shin, Yoon Young Choi, Joon Ho Choi, Kyung-Hyun Do
      Journal of the Korean Society of Magnetic Resonance in Medicine.2013; 17(3): 232.     CrossRef
    • Comparison of Breast Cancer Screening Results in Korean Middle-Aged Women: A Hospital-based Prospective Cohort Study
      TaeBum Lee
      Osong Public Health and Research Perspectives.2013; 4(4): 197.     CrossRef
    • Preoperative parathyroid hormone level as a predictive factor for post-thyroidectomy hypoparathyroidism
      Yoon-Hye Kwon, Kyu Eun Lee, Hyungju Kwon, June Young Choi, Do Hoon Koo, Eunyoung Kim, Yeo-Kyu Youn
      Korean Journal of Clinical Oncology.2013; 9(1): 28.     CrossRef
    • Complications Leading Reoperation after Gastrectomy in Patients with Gastric Cancer: Frequency, Type, and Potential Causes
      Ha Woo Yi, Su Mi Kim, Sang Hyun Kim, Jung Ho Shim, Min Gew Choi, Jun Ho Lee, Jae Hyung Noh, Tae Sung Sohn, Jae Moon Bae, Sung Kim
      Journal of Gastric Cancer.2013; 13(4): 242.     CrossRef
    • Cancer Screening in Korea, 2012: Results from the Korean National Cancer Screening Survey
      Mina Suh, Kui Son Choi, Yoon Young Lee, Boyoung Park, Jae Kwan Jun
      Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6459.     CrossRef
    • Recent Trends (1991-2010) of Metastatic Skin Cancers in Korea
      Chul Hwan Bang, Jung Min Bae, Hei Sung Kim, Gyeong Mun Kim, Dong Soo Yu, Hyun Jeong Park, Shin Tack Oh, Hoon Kang, Chul Jong Park, Jeong Deuk Lee, Jun Young Lee, Hyung Ok Kim, Young Min Park
      Journal of Korean Medical Science.2013; 28(7): 1083.     CrossRef
    • [6]-Gingerol Attenuates Autophagy and Increases Activities of Antioxidative Defense Enzymes in Mice with Cerulein-induced Acute Pancreatitis
      Sung Ok Kim, Yung Hyun Choi
      Journal of Life Science.2013; 23(10): 1280.     CrossRef
    • Burden of Noncommunicable Diseases and National Strategies to Control Them in Korea
      Young-Ho Khang
      Journal of Preventive Medicine & Public Health.2013; 46(4): 155.     CrossRef
    • Knowledge of and Practice Patterns for Hereditary Colorectal Cancer Syndromes in Korean Surgical Residents
      Jangho Park, Soo Young Lee, Duck-Woo Kim, Sung-Bum Kang, Seung-Yong Jeong, Kyu Joo Park
      Annals of Coloproctology.2013; 29(5): 186.     CrossRef
    • What Should Be Done to Increase Survival in Patients With Colorectal Cancer?
      Min Ro Lee, Jong Hun Kim
      Annals of Coloproctology.2013; 29(4): 135.     CrossRef
    • Survival of Korean Adult Cancer Patients by Stage at Diagnosis, 2006-2010: National Cancer Registry Study
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Aesun Shin, Jin-Soo Lee
      Cancer Research and Treatment.2013; 45(3): 162.     CrossRef
    • The Role of Gastrointestinal Endoscopy in the Treatment of Advanced Gastric Cancer
      Min Ho Choi
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2013; 13(3): 147.     CrossRef
    • Biochemically-verified Smoking Rate Trends and Factors Associated with Inaccurate Self-reporting of Smoking Habits in Korean Women
      Hyun Goo Kang, Kyoung Hyun Kwon, In Wook Lee, Boyoung Jung, Eun-Cheol Park, Sung-In Jang
      Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6807.     CrossRef
    • What Are Patients with Thyroid Cancer Surgery Concerned about?
      Hanna Kim, Yoon Hee Park, Young Ja Oh, Kyung Ah Park, In Sook Kim, Kum Myoung Woo, Bup-Woo Kim, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park
      Journal of Korean Thyroid Association.2013; 6(2): 115.     CrossRef
    • Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry
      Hyoung-Chul Park, Aesun Shin, Byung-Woo Kim, Kyu-Won Jung, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
      Annals of Coloproctology.2013; 29(4): 144.     CrossRef
    • Thyroid Cancer is the Most Common Cancer in Women, Based on the Data from Population-based Cancer Registries, South Korea
      S.-S. Kweon, M.-H. Shin, I.-J. Chung, Y.-J. Kim, J.-S. Choi
      Japanese Journal of Clinical Oncology.2013; 43(10): 1039.     CrossRef
    • Korean Risk Assessment Model for Breast Cancer Risk Prediction
      Boyoung Park, Seung Hyun Ma, Aesun Shin, Myung-Chul Chang, Ji-Yeob Choi, Sungwan Kim, Wonshik Han, Dong-Young Noh, Sei-Hyun Ahn, Daehee Kang, Keun-Young Yoo, Sue K. Park, Todd W. Miller
      PLoS ONE.2013; 8(10): e76736.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
      Cancer Res Treat. 2013;45(1):1-14.   Published online March 31, 2013
      Close
    • XML DownloadXML Download
    Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
    Image Image Image Image Image
    Fig. 1 Annual age-standardized cancer incidence and death rates for all sites during 1983-2010 in Korea by sex. Age standardization was based on the world standard population.
    Fig. 2 Trends in age-standardized incidences of selected cancers during 1999-2010 in Korea by sex. Age standardization was based on the world standard population. (A) Male. (B) Female.
    Fig. 3 Age-specific incidence rates of major cancers during 2010 in Korea. (A) Male. (B) Female.
    Fig. 4 Annual age-standardized mortalities of selected cancers during 1983-2010 in Korea by sex. Age standardization was based on the world standard population. (A) Male. (B) Female.
    Fig. 5 Numbers of prevalent cases for major cancer sites on January 1, 2011 in Korea by time since diagnosis.
    Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
    Site/Type New cases
    Deaths
    Prevalent casesa)
    Both Male Female Both Male Female Both Male Female
    All sites 202,053 103,014 99,039 72,046 45,209 26,837 960,654 434,365 526,289
    Lip, oral cavity and pharynx 2,695 1,916 779 963 742 221 13,961 9,464 4,497
    Esophagus 2,199 2,017 182 1,352 1,254 98 6,303 5,689 614
    Stomach 30,092 20,179 9,913 10,032 6,512 3,520 169,868 112,811 57,057
    Colon and rectum 25,782 15,612 10,170 7,645 4,322 3,323 136,055 80,717 55,338
    Liver 15,921 11,818 4,103 11,205 8,350 2,855 43,351 32,542 10,809
    Gallbladderb) 4,877 2,532 2,345 3,502 1,758 1,744 12,349 6,337 6,012
    Pancreas 4,637 2,505 2,132 4,306 2,323 1,983 5,583 3,052 2,531
    Larynx 1,144 1,071 73 416 383 33 7,583 7,120 463
    Lung 20,711 14,650 6,061 15,623 11,416 4,207 43,564 28,784 14,780
    Breast 14,277 69 14,208 1,868 10 1,858 103,418 472 102,946
    Cervix uteri 3,857 - 3,857 956 - 956 38,488 - 38,488
    Corpus uteri 1,752 - 1,752 222 - 222 11,935 - 11,935
    Ovary 1,981 - 1,981 895 - 895 11,782 - 11,782
    Prostate 7,848 7,848 - 1,328 1,328 - 35,372 35,372 -
    Testis 206 206 - 9 9 - 1,774 1,774 -
    Kidney 3,598 2,520 1,078 797 562 235 20,203 13,639 6,564
    Bladder 3,415 2,752 663 1,100 822 278 21,921 17,823 4,098
    Brain and CNS 1,715 922 793 1,182 645 537 7,527 3,951 3,576
    Thyroid 36,021 6,231 29,790 356 94 262 174,918 26,264 148,654
    Hodgkin lymphoma 243 167 76 48 30 18 1,609 1,035 574
    Non-Hodgkin lymphoma 3,940 2,171 1,769 1,457 817 640 20,838 11,394 9,444
    Multiple myeloma 1,070 563 507 763 399 364 3,073 1,624 1,449
    Leukemia 2,684 1,540 1,144 1,618 922 696 12,287 6,793 5,494
    Other and ill-defined 11,388 5,725 5,663 4,403 2,511 1,892 56,892 27,708 29,184
    Site/Type Crude incidence rate per 100,000
    Age-standardized incidence rate
    per 100,000a)
    Both Male Female Both Male Female
    All sites 405.1 412.4 397.7 286.4 324.1 268.7
    Lip, oral cavity, and pharynx 5.4 7.7 3.1 3.9 5.9 2.1
    Esophagus 4.4 8.1 0.7 3.1 6.4 0.4
    Stomach 60.3 80.8 39.8 41.8 62.3 24.9
    Colon and rectum 51.7 62.5 40.8 35.9 48.6 25.3
    Liver 31.9 47.3 16.5 22.3 36.0 10.2
    Gallbladderb) 9.8 10.1 9.4 6.5 8.1 5.4
    Pancreas 9.3 10.0 8.6 6.3 7.9 4.9
    Larynx 2.3 4.3 0.3 1.6 3.4 0.2
    Lung 41.5 58.7 24.3 28.0 46.5 14.3
    Breast 28.6 0.3 57.1 20.2 0.2 39.8
    Cervix uteri 7.7 - 15.5 5.5 - 10.6
    Corpus uteri 3.5 - 7.0 2.5 - 5.0
    Ovary 4.0 - 8.0 2.9 - 5.7
    Prostate 15.7 31.4 - 10.7 25.3 -
    Testis 0.4 0.8 - 0.4 0.8 -
    Kidney 7.2 10.1 4.3 5.2 7.8 3.0
    Bladder 6.8 11.0 2.7 4.6 8.7 1.5
    Brain and CNS 3.4 3.7 3.2 3.0 3.4 2.6
    Thyroid 72.2 24.9 119.6 52.7 18.3 87.4
    Hodgkin lymphoma 0.5 0.7 0.3 0.4 0.6 0.3
    Non-Hodgkin lymphoma 7.9 8.7 7.1 6.0 7.1 5.0
    Multiple myeloma 2.1 2.3 2.0 1.5 1.7 1.3
    Leukemia 5.4 6.2 4.6 5.0 6.0 4.1
    Other and ill-defined 22.8 22.9 22.7 16.7 19.0 14.9
    Rank Cause of death No. of deaths Deaths (%) Age-standardized death rate
    per 100,000a)
    All causes 255,405 100.0 344.8
    1 Cancer 69,780 28.2 96.3
    2 Cerebrovascular disease 25,838 10.4 33.3
    3 Heart disease 22,347 9.2 30.1
    4 Intentional self-harm (suicide) 15,413 6.1 23.4
    5 Diabetes mellitus 9,757 4.1 13.1
    6 Pneumonia 7,147 2.9 9.4
    7 Chronic lower respiratory diseases 6,914 2.8 8.7
    8 Disease of the liver 6,868 2.7 9.5
    9 Transport accidents 6,324 2.7 10.8
    10 Hypertensive diseases 4,749 1.9 6.0
    Others 74,485 29.2 104.3
    Site/Type Crude mortality rate per 100,000
    Age-standardized mortality rate
    per 100,000a)
    Both Male Female Both Male Female
    All sites 144.4 181.0 107.8 96.3 144.7 61.6
    Lip, oral cavity, and pharynx 1.9 3.0 0.9 1.3 2.3 0.5
    Esophagus 2.7 5.0 0.4 1.8 4.0 0.2
    Stomach 20.1 26.1 14.1 13.2 20.7 7.8
    Colon and rectum 15.3 17.3 13.3 10.1 14.0 7.3
    Liver 22.5 33.4 11.5 15.4 25.8 6.6
    Gallbladderb) 7.0 7.0 7.0 4.5 5.7 3.7
    Pancreas 8.6 9.3 8.0 5.7 7.4 4.4
    Larynx 0.8 1.5 0.1 0.5 1.2 0.1
    Lung 31.3 45.7 16.9 20.5 36.6 9.1
    Breast 3.7 0.0 7.5 2.6 0.0 5.0
    Cervix uteri 1.9 - 3.8 1.3 - 2.3
    Corpus uteri 0.4 - 0.9 0.3 - 0.6
    Ovary 1.8 - 3.6 1.2 - 2.3
    Prostate 2.7 5.3 - 1.6 4.6 -
    Testis 0.0 0.0 - 0.0 0.0 -
    Kidney 1.6 2.3 0.9 1.1 1.8 0.5
    Bladder 2.2 3.3 1.1 1.4 2.8 0.5
    Brain and CNS 2.4 2.6 2.2 1.8 2.2 1.4
    Thyroid 0.7 0.4 1.1 0.5 0.3 0.5
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 2.9 3.3 2.6 2.0 2.6 1.5
    Multiple myeloma 1.5 1.6 1.5 1.0 1.3 0.8
    Leukemia 3.2 3.7 2.8 2.5 3.1 1.9
    Other and ill-defined 8.8 10.1 7.6 6.0 8.2 4.4
    Site/Type Year
    APC
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
    All sites 210.5 205.1 216.7 220.1 227.4 234.5 247.3 251.4 262.3 274.5 284.6 286.4 3.3a)
    Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.8 3.9 0.2
    Esophagus 4.1 3.7 3.9 3.8 3.6 3.5 3.5 3.4 3.3 3.3 3.1 3.1 -2.2a)
    Stomach 43.6 42.3 44.0 43.6 43.2 41.1 44.4 42.8 41.7 42.5 43.3 41.8 -0.2
    Colon and rectum 20.4 21.0 22.9 24.7 26.8 28.6 30.9 32.4 33.6 34.6 36.6 35.9 5.9a)
    Liver 27.9 26.7 27.3 26.5 25.7 25.6 25.8 24.5 24.3 24.0 23.4 22.3 -1.8a)
    Gallbladderb) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.6 6.4 6.7 6.5 0.0
    Pancreas 5.6 5.5 5.5 5.8 5.9 6.0 6.3 6.2 6.3 6.4 6.3 6.3 1.4a)
    Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.6 1.7 1.6 -3.6a)
    Lung 28.5 27.7 28.3 28.5 27.9 28.8 28.9 28.7 28.4 28.1 28.1 28.0 0.0
    Breast 10.7 10.8 12.7 13.9 14.2 14.9 16.2 16.9 18.0 18.8 19.5 20.2 6.1a)
    Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.7 5.9 5.5 5.5 -4.3a)
    Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 2.4 2.6 2.5 6.0a)
    Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.0 2.9 2.7 2.9 1.3a)
    Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.3 8.6 9.7 10.5 10.7 14.3a)
    Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 4.0a)
    Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.0 5.2 5.2 6.1a)
    Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.5 4.6 -0.1
    Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.0 3.0 3.0 0.8a)
    Thyroid 6.3 6.1 7.9 9.5 12.8 17.2 20.7 25.4 32.8 41.3 47.9 52.7 24.2a)
    Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 4.6a)
    Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 4.9 5.3 5.3 5.5 5.5 5.6 6.1 6.0 3.3a)
    Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 1.5 4.0a)
    Leukemia 4.7 4.3 4.7 4.8 4.8 4.8 4.7 4.9 4.8 5.0 5.0 5.0 0.9a)
    Other and ill-defined 14.3 13.5 13.9 13.5 15.1 15.2 16.1 16.0 17.0 16.9 16.8 16.7 -
    Site/Type Year
    APC
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
    All sites 285.0 276.7 288.3 290.0 294.6 299.2 311.0 309.6 315.8 322.5 328.3 324.1 1.5a)
    Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.2 6.1 6.1 6.3 6.5 6.1 5.9 -0.5
    Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 6.9 7.0 6.6 6.4 -2.6a)
    Stomach 66.2 65.0 67.2 66.6 65.9 62.3 66.9 65.3 63.0 64.3 64.8 62.3 -0.4a)
    Colon and rectum 26.2 27.2 29.6 32.9 35.3 37.9 41.1 43.2 45.2 46.7 49.6 48.6 6.4a)
    Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.2 39.7 39.3 38.0 36.0 -2.1a)
    Gallbladderb) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.0 8.1 -0.1
    Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.4 8.1 7.9 0.6a)
    Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.7 3.8 3.5 3.6 3.4 -3.6a)
    Lung 51.4 49.8 51.1 51.0 49.9 50.8 50.8 49.2 48.7 47.5 47.3 46.5 -0.8a)
    Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 -1.6
    Prostate 8.4 7.2 9.5 10.1 12.4 15.1 15.7 17.9 20.8 23.4 24.9 25.3 12.8a)
    Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 3.9a)
    Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.0 7.4 7.6 7.8 5.8a)
    Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.4 9.1 8.6 8.7 -0.3
    Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.1 3.4 3.4 3.4 3.4 1.0a)
    Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.3 15.5 18.3 24.8a)
    Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.6 3.7a)
    Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.5 6.9 7.0 6.8 7.4 7.1 2.5a)
    Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.5 1.6 1.7 1.9 1.7 3.4a)
    Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.6 5.6 5.7 5.8 5.9 6.0 1.0a)
    Other and ill-defined 17.9 16.5 16.8 16.5 18.4 18.2 19.2 18.7 20.1 19.6 19.7 19.0 -
    Site/Type Year
    APC
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
    All sites 161.1 157.4 169.0 174.6 184.1 193.1 207.3 215.9 231.2 248.3 261.8 268.7 5.3a)
    Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 2.1 1.0
    Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 0.4 -2.8a)
    Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.0 24.7 25.1 25.6 24.9 -0.4
    Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.5 22.9 24.0 24.5 25.0 26.1 25.3 4.7a)
    Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.4 11.1 11.1 10.6 10.6 10.2 -1.6a)
    Gallbladderb) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.8 5.4 0.0
    Pancreas 4.0 4.0 4.0 4.2 4.5 4.5 4.7 4.7 4.7 4.9 4.8 4.9 2.2a)
    Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 -7.7a)
    Lung 12.4 12.5 12.3 2.6 12.4 13.0 13.5 14.0 13.9 14.1 14.0 14.3 1.6a)
    Breast 20.9 20.9 24.7 27.2 27.8 29.2 31.8 33.2 35.5 37.0 38.5 39.8 6.3a)
    Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.1 12.3 12.2 11.0 11.4 10.6 10.6 -4.2a)
    Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.1 5.0 6.2a)
    Ovary 5.0 4.8 4.8 5.0 5.1 5.2 5.4 5.4 5.9 5.6 5.3 5.7 1.6a)
    Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.2 3.0 6.0a)
    Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.6 1.5 -0.7
    Brain and CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.6 2.8 2.6 2.5 2.6 0.5
    Thyroid 10.4 10.1 13.2 16.2 21.8 29.5 35.3 43.2 55.5 69.3 80.4 87.4 24.2a)
    Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 5.9a)
    Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.4 4.4 4.3 4.7 5.0 5.0 4.3a)
    Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.3 4.7a)
    Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.2 4.3 4.2 4.1 0.7a)
    Other and ill-defined 11.8 11.5 11.8 11.5 12.7 13.0 13.8 14.0 14.6 14.8 14.6 14.9 -
    Rank Age (yr)
    0-14 15-34 35-64 ≥65
    Male
    1 Leukemia Thyroid Stomach Lung
    (5.1) (11.2) (95.2) (455.0)
    2 Brain and CNS Leukemia Colon and rectum Stomach
    (2.5) (3.1) (72.1) (433.2)
    3 Non-Hodgkin lymphoma Colon and rectum Liver Colon and rectum
    (2.0) (2.7) (66.4) (340.6)
    4 Kidney Non-Hodgkin lymphoma Thyroid Prostate
    (0.5) (2.6) (42.9) (274.1)
    5 Testis Stomach Lung Liver
    (0.3) (2.6) (42.5) (199.3)
    Female
    1 Leukemia Thyroid Thyroid Colon and rectum
    (3.6) (59.9) (209.8) (175.7)
    2 Brain and CNS Breast Breast Stomach
    (1.7) (10.0) (106.5) (162.2)
    3 Ovary Cervix uteri Stomach Lung
    (0.8) (5.6) (40.8) (121.5)
    4 Thyroid Stomach Colon and rectum Thyroid
    (0.7) (4.3) (40.5) (85.0)
    5 Non-Hodgkin lymphoma Ovary Cervix uteri Liver
    (0.6) (3.0) (23.0) (77.8)
    Site/Type Both
    Male
    Female
    1993-1995 1996-2000 2001-2005 2006-2010 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 Changea)
    All sites 41.2 44.0 53.7 64.1 22.9 31.7 35.3 45.2 55.4 23.7 53.4 55.3 63.9 73.3 19.9
    Lip, oral cavity, and pharynx 41.1 46.7 54.1 60.1 19.0 35.8 41.1 49.3 56.3 20.5 58.1 63.8 67.7 70.2 12.1
    Esophagus 12.7 15.2 21.1 29.4 16.7 11.8 14.3 20.4 28.7 16.9 23.7 24.2 29.5 36.8 13.1
    Stomach 42.8 46.6 57.7 67.0 24.2 43.0 46.9 58.4 67.7 24.7 42.6 46.0 56.3 65.7 23.1
    Colon and rectum 54.8 58.0 66.6 72.6 17.8 55.3 59.0 68.5 74.5 19.2 54.2 56.8 64.1 69.9 15.7
    Liver 10.7 13.2 20.1 26.7 16.0 9.9 12.9 20.1 26.7 16.8 13.6 14.2 20.3 26.8 13.2
    Gallbladderb) 17.3 19.7 22.8 26.7 9.4 16.6 20.3 23.3 27.9 11.3 18.0 19.1 22.3 25.5 7.5
    Pancreas 9.4 7.6 8.0 8.0 -1.4 8.8 7.3 8.0 7.7 -1.1 10.1 8.1 8.1 8.3 -1.8
    Larynx 59.7 62.3 66.1 72.3 12.6 60.2 62.8 66.7 72.7 12.5 55.4 57.8 58.2 66.0 10.6
    Lung 11.3 12.7 16.2 19.7 8.4 10.4 11.6 14.9 17.5 7.1 14.2 16.2 19.7 25.4 11.2
    Breast 77.9 83.2 88.5 91.0 13.1 75.1 85.6 87.0 89.6 14.5 78.0 83.2 88.5 91.0 13.0
    Cervix uteri 77.5 80.0 81.2 80.2 2.7 - - - - - 77.5 80.0 81.2 80.2 2.7
    Corpus uteri 81.5 81.8 84.6 86.2 4.7 - - - - - 81.5 81.8 84.6 86.2 4.7
    Ovary 58.7 58.9 61.3 60.4 1.7 - - - - - 58.7 58.9 61.3 60.4 1.7
    Prostate 55.9 67.2 80.1 90.2 34.3 55.9 67.2 80.1 90.2 34.3 - - - - -
    Testis 85.4 90.4 90.6 92.5 7.1 85.4 90.4 90.6 92.5 7.1 - - - - -
    Kidney 62.0 66.1 73.3 77.7 15.7 60.8 64.4 72.8 77.7 16.9 64.5 69.7 74.4 77.8 13.3
    Bladder 69.1 73.1 75.5 76.3 7.2 70.0 74.8 77.3 78.3 8.3 65.5 66.3 68.5 68.4 2.9
    Brain and CNS 38.5 39.0 40.5 42.6 4.1 37.2 37.5 39.9 41.4 4.2 40.2 40.7 41.2 44.0 3.8
    Thyroid 94.2 94.9 98.3 99.8 5.6 87.2 89.5 95.8 99.8 12.6 95.4 95.9 98.7 99.7 4.3
    Hodgkin lymphoma 68.0 71.2 76.7 80.8 12.8 67.6 68.1 74.7 80.4 12.8 68.6 77.4 80.6 81.4 12.8
    Non-Hodgkin lymphoma 46.6 50.8 59.9 64.9 18.3 45.3 48.9 58.0 63.2 17.9 48.7 53.5 62.3 67.0 18.3
    Multiple myeloma 22.1 19.8 29.2 35.1 13.0 21.1 17.8 29.5 35.3 14.2 23.3 22.1 28.9 34.9 11.6
    Leukemia 26.5 33.3 41.8 47.2 20.7 26.2 32.3 41.6 46.2 20.0 26.8 34.6 41.9 48.4 21.6
    Other and ill-defined 42.1 45.9 55.6 64.2 22.1 37.4 42.4 52.0 60.4 23.0 47.4 50.0 59.6 68.1 20.7
    Site/Type Crude prevalence rate per 100,000a)
    Age-standardized prevalenc rate
    per 100,000b)
    Both Male Female Both Male Female
    All sites 1925.9 1739.0 2113.4 1370.9 1369.7 1446.7
    Lip, oral cavity, and pharynx 28.0 37.9 18.1 20.2 29.3 12.4
    Esophagus 12.6 22.8 2.5 8.8 18.0 1.5
    Stomach 340.6 451.7 229.1 236.4 349.3 144.6
    Colon and rectum 272.8 323.2 222.2 188.8 252.4 138.7
    Liver 86.9 130.3 43.4 62.5 100.1 28.9
    Gallbladderc) 24.8 25.4 24.1 16.9 20.0 14.6
    Pancreas 11.2 12.2 10.2 7.8 9.6 6.4
    Larynx 15.2 28.5 1.9 10.6 22.6 1.1
    Lung 87.3 115.2 59.4 60.5 90.8 37.4
    Breast 207.3 1.9 413.4 145.8 1.5 286.0
    Cervix uteri 77.2 - 154.6 53.9 - 104.5
    Corpus uteri 23.9 - 47.9 17.2 - 33.7
    Ovary 23.6 - 47.3 17.7 - 34.9
    Prostate 70.9 141.6 - 46.5 114.1 -
    Testis 3.6 7.1 - 3.3 6.4 -
    Kidney 40.5 54.6 26.4 29.5 42.3 18.4
    Bladder 43.9 71.4 16.5 29.5 56.5 9.4
    Brain and CNS 15.1 15.8 14.4 13.5 14.5 12.5
    Thyroid 350.7 105.2 596.9 253.0 76.9 427.5
    Hodgkin lymphoma 3.2 4.1 2.3 2.8 3.5 2.0
    Non-Hodgkin lymphoma 41.8 45.6 37.9 31.9 37.1 27.5
    Multiple myeloma 6.2 6.5 5.8 4.4 5.0 3.8
    Leukemia 24.6 27.2 22.1 24.2 27.0 21.5
    Other and ill-defined 114.1 110.9 117.2 85.1 92.6 79.2
    Table 1 Numbers of incident cancer cases, deaths, and prevalent cancer cases during 2010 in Korea by sex

    CNS, central nervous system. a)Limited-duration prevalent cases on January 1, 2011. These are patients who were diagnosed between January 1, 1999 and December 31, 2010 and who were known alive on January 1, 2011. Multiple primary cancer cases were counted multiple times, b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 2 Crude and age-standardized cancer incidence rates during 2010 in Korea by sex

    CNS, central nervous system. a)Age-adjusted using the world standard population, b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 3 The 10 leading causes of death in Korea during 2010

    Source: Mortality data, 2010, Statistics Korea [1]. a)Age-adjusted using the world standard population.

    Table 4 Crude and age-standardized cancer mortality rates during 2010 in Korea by sex

    CNS, central nervous system. a)Age-adjusted using the world standard population, b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 5 Trends in cancer incidence rates in both sexes during 1999-2010 in Korea

    APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the world standard population. a)Significantly different from zero (p<0.05), b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 6 Trends in cancer incidence rates in males during 1999-2010 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system. a)Significantly different from zero (p<0.05), b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 7 Trends in cancer incidence rates in females during 1999-2010 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system. a)Significantly different from zero (p<0.05), b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 8 The five major sites of cancer incidence during 2010 in Korea by age group and sex

    CNS, central nervous system.

    Table 9 Trends in the 5-year relative survival rates (%) during 1993-2010 in Korea by year of diagnosis

    CNS, central nervous system. a)Change in 5-year relative survival between 1993-1995 and 2006-2010 as a percentage. b)Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 10 Crude and age-standardized rates of cancer prevalence on January 1, 2011 in Korea by sex

    CNS, central nervous system. a)Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2010 and who were alive on January 1, 2011. Multiple primary cancer cases were counted multiple times, b)Age-adjusted using the world standard population, c)Includes the gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP